<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="chapter-article"><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><?noissn?><front><journal-meta><journal-id journal-id-type="publisher-id">978-3-030-33803-9</journal-id><journal-id journal-id-type="doi">10.1007/978-3-030-33803-9</journal-id><journal-id journal-id-type="nlm-ta">Highly Infectious Diseases in Critical Care</journal-id><journal-title-group><journal-title>Highly Infectious Diseases in Critical Care</journal-title><journal-subtitle>A Comprehensive Clinical Guide</journal-subtitle></journal-title-group><isbn publication-format="print">978-3-030-33802-2</isbn><isbn publication-format="electronic">978-3-030-33803-9</isbn></journal-meta><article-meta><article-id pub-id-type="pmcid">7120728</article-id><article-id pub-id-type="publisher-id">5</article-id><article-id pub-id-type="doi">10.1007/978-3-030-33803-9_5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Influenza, Measles, SARS, MERS, and Smallpox</article-title></title-group><contrib-group content-type="book editors"><contrib contrib-type="editor"><name><surname>Hidalgo</surname><given-names>Jorge</given-names></name><address><email>jlhmmd@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="editor"><name><surname>Woc-Colburn</surname><given-names>Laila</given-names></name><address><email>woccolbu@bcm.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Division of Critical Care, Karl Heusner Memorial Hospital, Belize City, Belize </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.39382.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2160 926X</institution-id><institution>National School of Tropical Medicine, </institution><institution>Baylor College of Medicine, </institution></institution-wrap>Houston, TX USA </aff></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Chertow</surname><given-names>Daniel S.</given-names></name><address><email>chertowd@cc.nih.gov</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kindrachuk</surname><given-names>Jason</given-names></name><address><email>Jason.Kindrachuk@umanitoba.ca</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.419681.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2164 9667</institution-id><institution>Critical Care Medicine Department, </institution><institution>National Institutes of Health Clinical Center and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, </institution></institution-wrap>Bethesda, MD USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.21613.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9609</institution-id><institution>Laboratory of Emerging and Re-Emerging Viruses, Department of Medical Microbiology, </institution><institution>University of Manitoba, </institution></institution-wrap>Winnipeg, MB Canada </aff></contrib-group><pub-date pub-type="epub"><day>03</day><month>01</month><year>2020</year></pub-date><fpage>69</fpage><lpage>96</lpage><permissions><copyright-statement>&#x000a9; Springer Nature Switzerland AG 2020</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Influenza, measles, SARS, MERS, and smallpox illnesses are caused by highly infectious viral pathogens that induce critical illness. These biologically diverse viruses enter and replicate within host cells triggering viral- and host-mediated damage that results in pneumonia and multiorgan failure in severe cases. Early case identification and strict infection control limit healthcare transmission. Vaccination allowed smallpox eradication and limits global measles and seasonal influenza mortality. While SARS-coronavirus (CoV) is no longer circulating, MERS-CoV and zoonotic influenza viruses, with pandemic potential, remain persistent threats. Supportive critical care is the mainstay of treatment for severe disease due to these viral infections.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Influenza</kwd><kwd>Measles</kwd><kwd>SARS</kwd><kwd>MERS</kwd><kwd>Smallpox</kwd><kwd>Pathogenesis</kwd><kwd>Treatment</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Switzerland AG 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>The Viruses</title><sec id="Sec2"><title>Influenza Biology</title><p id="Par2">Influenza viruses are spherical orfilamentous, enveloped, negative-sense, single-stranded RNA viruses of family <italic>Orthomyxoviridae</italic> of approximately 100 nm to 300 nm in diameter that include types A, B, C, and D [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Influenza A and B viruses cause mild to severe illness during seasonal epidemics, and influenza A viruses
cause intermittent pandemics. Influenza C viruses cause mild infections but not epidemics, and influenza D virus may cause subclinical infection [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Influenza A viruses are classified into subtypes based on the combination of the surface glycoproteins hemagglutinin and neuraminidase, with 18 H and 11 N known subtypes [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. Specific influenza strains are named according to the World Health Organization (WHO) convention designating influenza virus type, host of origin (if not human), geographic origin, strain number, year of isolation, and subtype (for influenza A viruses) (e.g., Influenza A/California/7/2009[H1N1]) [<xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par3">Influenza A viruses
have eight genome segments that code for structural and nonstructural proteins (Fig. <xref rid="Fig1" ref-type="fig">5.1a</xref>) [<xref ref-type="bibr" rid="CR9">9</xref>]. Surface glycoproteins include hemagglutinin (HA), required for viral binding and entry, and neuraminidase (NA), required for viral budding. Matrix (M1) protein underlies the host-derived lipid envelope providing structure, and M2 protein is an ion channel integrated into the envelope. Eight single-stranded RNA viral genome segments are coated with nucleoprotein (N) and bound by the polymerase complex, composed of basic polymerase 1 (PB1), PB2, and acidic polymerase (PA). Nuclear export protein (NEP) mediates trafficking of viral RNA segments and nonstructural protein (NS1) inhibits host antiviral responses. The virus can also expressaccessory proteins PB1-F2 and PA-x.<fig id="Fig1"><label>Fig. 5.1</label><caption><p>Schematic of viral structures and key epidemiological features. (<bold>a</bold>) <italic>Influenza</italic> virus is spherical or filamentous in shape. Hemagglutinin (HA) and neuraminidase (NA) proteins are integrated into the host-derived lipid envelope and project from the viral surface. Matrix (M1) protein underlies the envelope, and M2 forms an ion channel within the envelope. Eight single-stranded RNA genome segments are coated with nucleoprotein (NP) and bound by the polymerase complex. Nuclear export protein (NEP) mediates export of viral RNA. Influenza has estimated reproductive number (R<sub>0</sub>) between 1 and 2. Standard, droplet, and contract precautions are recommended to prevent nosocomial transmission. (<bold>b</bold>) virus is pleomorphic in shape. Hemagglutinin (H) and fusion (F) proteins are integrated into the host-derived lipid envelope, and matrix (M) protein underlies the envelope. The single-stranded RNA genome is coated with nucleoprotein (N) and bound by the polymerase complex. Measles has an estimate R<sub>0</sub> between 9 and 18. Standard, airborne, and contact precautions are recommended to prevent nosocomial transmission. (<bold>c</bold>) are spherical in shape. Spike (S), membrane (M), and envelope (E) proteins are integrated into the host-derived lipid envelope. The single-stranded RNA genome is coated with nucleoprotein (N). SARS and MERS have an estimated R<sub>0</sub> of &#x0003c;1&#x02013;2. Standard, airborne, and contact precautions are recommended to prevent nosocomial transmission. (<bold>d</bold>) are oval to brick shaped. The biconcave viral core contains double-stranded DNA and several proteins organized as a nucleosome and surrounded by a core membrane. Two proteinaceous lateral bodies flank the core, and a single lipid membrane surrounds the cell-associated form of the mature virion (MV). A second host-derived lipid envelope covers the extracellular virion (EV). Smallpox has an estimated R<sub>0</sub> between 4 and 6. Standard, airborne, and contact precautions are recommended to prevent nosocomial transmission of smallpox</p></caption><graphic xlink:href="470289_1_En_5_Fig1a_HTML" id="d29e380"/><graphic xlink:href="470289_1_En_5_Fig1b_HTML" id="d29e381"/><graphic xlink:href="470289_1_En_5_Fig1c_HTML" id="d29e382"/><graphic xlink:href="470289_1_En_5_Fig1d_HTML" id="d29e383"/></fig>
</p></sec><sec id="Sec3"><title>Measles (Rubeola Virus) Biology</title><p id="Par4">Measles virus
is a pleomorphic, enveloped, negative-sense, single-stranded RNA virus of family of approximately 100 nm to 300 nm in diameter [<xref ref-type="bibr" rid="CR2">2</xref>]. Measles virus causes mild to severe illness during seasonal outbreaks in endemic areas and intermittent outbreaks in nonendemic area [<xref ref-type="bibr" rid="CR10">10</xref>]. Measles virus codes for six structural and two nonstructural proteins (Fig. <xref rid="Fig1" ref-type="fig">5.1b</xref>) [<xref ref-type="bibr" rid="CR11">11</xref>]. Hemagglutinin (H) and fusion (F) glycoproteins project from the viral surface and facilitateviral binding to cellular receptors and fusion with the host cell membrane, respectively. Matrix (M) protein underlies the envelope providing structure. The inner nucleocapsid is composed of RNA coated by nucleoprotein (N), bound by the polymerase complex which includes the large (L) polymerase protein, and phosphoprotein (P), a polymerase cofactor. The remaining nonstructuralproteins include C and V.</p></sec><sec id="Sec4"><title>Coronavirus Biology</title><p id="Par5">
Coronaviruses are spherical, enveloped, positive-sense, single-stranded RNA viruses of family <italic>Coronaviridae</italic> of approximately 120 nm in diameter [<xref ref-type="bibr" rid="CR12">12</xref>]. Coronaviruses are the causative agents of an estimated 30% of upper and lower respiratory tract infections in humans resulting in rhinitis, pharyngitis, sinusitis, bronchiolitis, and pneumonia [<xref ref-type="bibr" rid="CR13">13</xref>]. While coronaviruses are often associated with mild disease (e.g., HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1), severe acute respiratory syndrome coronavirus (SARS-CoV), a lineage B betacoronavirus, and Middle East respiratory syndrome coronavirus (MERS-CoV), a lineage C betacoronavirus, are associated with severe and potentially fatal respiratory infection [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par6">SARS- and MERS-CoV transcribe 12 and 9 subgenomic RNAs, respectively, which encode for the spike (S), envelope (E), membrane (M), and nucleocapsid (N) structural proteins (Fig. <xref rid="Fig1" ref-type="fig">5.1c</xref>) [<xref ref-type="bibr" rid="CR14">14</xref>]. S, E, and M are all integrated into the host-derived lipid envelope, and S facilitates host cell attachment to angiotensin-converting enzyme (ACE)-2 receptors for SARS-CoV and dipeptidyl peptidase (DPP)-4 receptors for MERS-CoV [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. The N protein encapsidates the viral genome to form the helical nucleocapsid. The viral replicase-transcriptase complex is made up of 16 nonstructural proteins (nsp1&#x02013;16) including a unique proofreading exoribonuclease that reduces the accumulation of genomemutations [<xref ref-type="bibr" rid="CR12">12</xref>].</p></sec><sec id="Sec5"><title>Smallpox (Variola Virus) Biology</title><p id="Par7">
Poxviruses areoval-to-brick-shaped double-stranded DNA viruses of family <italic>Poxviridae</italic> that range in size from 200 to 400 nm [<xref ref-type="bibr" rid="CR2">2</xref>]. Viruses within genus that cause human disease include cowpox virus (CPXV), monkeypox virus (MPXV), vaccinia virus (VACV), and variola virus (VARV), the etiologic agent of smallpox [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par8">
Poxviruses contain a biconcave viral core where the DNA genome, DNA-dependent RNA polymerase, and enzymes necessary for particle uncoating reside (Fig. <xref rid="Fig1" ref-type="fig">5.1d</xref>) [<xref ref-type="bibr" rid="CR19">19</xref>]. This nucleosome is surrounded by a core membrane that is flanked by two proteinaceous lateral bodies. A singlelipid membrane surrounds the cell-associated form of the mature virion (MV). A second host-derived lipid envelope covers the extracellular virion (EV) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Poxvirus genomes are comprised of a large, linear double-stranded viral DNA genome that encodes ~200 genes. Highly conserved structural genes are predominantly found in the middle of the genome, whereas variable virulence factor genes that function in immune evasion, virulence,and viral pathogenesis are found at the termini of the genome [<xref ref-type="bibr" rid="CR20">20</xref>].</p></sec></sec><sec id="Sec6"><title>Ecology and Epidemiology</title><sec id="Sec7"><title>Avian, Swine, Seasonal, and Pandemic Influenza A Viruses</title><p id="Par9">Wild aquatic birds are natural reservoirsfor nearly all influenza A virus subtypes, which spread to domestic avian species and mammals, including humans [<xref ref-type="bibr" rid="CR5">5</xref>]. H17N10 and H18N11 subtypes are exceptions in that they have only been isolated from bats [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Certain H5 and H7 subtypes are highly pathogenic to domestic poultry when transmitted from wild birds, known as highly pathogenic avian influenza (HPAI) viruses [<xref ref-type="bibr" rid="CR21">21</xref>]. HPAIviruses cause spillover infections in humans that may be severe or fatal. Examples include outbreaks of H5N1 and H7N9 HPAI viruses in Asia with high case fatality among humans, although limited human-to-human transmission [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] has been reported. HPAI virus adaptations might lead to sustained human-to-human transmission, and so poultry outbreaks are managed by flock depopulation [<xref ref-type="bibr" rid="CR24">24</xref>]. Influenza A subtypes isolated in swine include H1 to H5, H9, and N1 and N2. Subtypes that spillover into humans cause mild to severe illness and are known as swine &#x0201c;variant&#x0201d; viruses [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par10">Currently circulating seasonalinfluenza A subtypes H1N1 and H3N2 and influenza B viruses, Yamagata or Victoria lineage, cause annual epidemics during fall through spring in temperate regions and infections throughout the year in the tropics [<xref ref-type="bibr" rid="CR26">26</xref>]. Antigenic drift of H and N surface glycoproteins drives annual epidemics. From 2017 to 2018, seasonal influenza caused approximately 49 million illnesses, 1&#x000a0;million hospitalizations, and 79,000 deaths in the United States alone [<xref ref-type="bibr" rid="CR27">27</xref>]. When two or more influenza A viruses infect a common host, such as a bird or pig, individual gene segments may recombine to form a novel virus, known as antigenic shift. Influenza pandemics occur when novel viruses emerge into an immunologically na&#x000ef;ve population and become adapted for sustained human-to-human spread. The 1918 &#x0201c;Spanish&#x0201d; influenza pandemic was the most severe on record, resulting in anestimated 50 million deaths [<xref ref-type="bibr" rid="CR28">28</xref>]. Less severe pandemics occurred in 1957, 1968, and 2009. In an effort to improve preparedness and response to seasonal, pandemic, and zoonotic influenza, the World HealthOrganization (WHO) conducts global surveillance of influenza A and B isolates (Fig. <xref rid="Fig2" ref-type="fig">5.2a</xref>) [<xref ref-type="bibr" rid="CR29">29</xref>].<fig id="Fig2"><label>Fig. 5.2</label><caption><p>Viral disease burden reported by WHO region. (<bold>a</bold>) WHO global influenza surveillance of laboratory confirmed influenza A and B infections, 2008&#x02013;2018. (<bold>b</bold>) Global measles cases reported to WHO, 2011&#x02013;2018. Reported cases from 1980 are used as a reference. (<bold>c</bold>) Global cases of SARS- and MERS-CoV infections. (<bold>d</bold>) Global cases of smallpox from 1920 to 1970. Data represents the cumulative cases for that year. WHO regions are as follows: WPR Western Pacific Region, SEAR South-East Asia Region, EUR European Region, EMR Eastern Mediterranean Region, AMR Region of the Americas, AFR African Region. (Data courtesy of WHO)</p></caption><graphic xlink:href="470289_1_En_5_Fig2a_HTML" id="d29e738"/><graphic xlink:href="470289_1_En_5_Fig2b_HTML" id="d29e739"/></fig>
</p></sec><sec id="Sec8"><title>Endemic and Epidemic Measles</title><p id="Par11">
Measles is pathogenic for humans and nonhuman primates, although sustained transmission occurs only among humans raising potential for global elimination [<xref ref-type="bibr" rid="CR30">30</xref>]. Historically, measles infected an estimated 90% of children by age 5&#x000a0;years, resulting in approximately 2 million global deaths each year [<xref ref-type="bibr" rid="CR10">10</xref>]. With the introduction of the measles vaccine in1963 and advances in global vaccination programs, measles cases and mortality have drastically declined (Fig. <xref rid="Fig2" ref-type="fig">5.2b</xref>). By 2017, 85% of children worldwide had received at least one dose of the measles vaccine by age 1&#x000a0;year, and during 2000&#x02013;2017, global measles mortality decreased by 80%, preventing an estimated 21 million deaths [<xref ref-type="bibr" rid="CR31">31</xref>]. Of the 24 known measles genotypes, only five were detected in circulation during2016&#x02013;2017. Despite these gains, measles remains endemic in many regions of the world including Africa, Western Pacific, South East Asia, and Europe, and measles has resurged in previously low-incidence areas (e.g., regions within Europe and the Americas) with epidemics attributable to importation of cases and suboptimal immunization coverage [<xref ref-type="bibr" rid="CR32">32</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>]. An estimated 93% population immunity is required to preventmeasles transmission within communities, a prerequisite for global elimination [<xref ref-type="bibr" rid="CR35">35</xref>].</p></sec><sec id="Sec9"><title>SARS and MERS Epidemics</title><p id="Par12">Chinese horseshoe bats are the putative reservoir for
SARS-CoV, and dromedary camels are thought to be the reservoir for MERS-CoV [<xref ref-type="bibr" rid="CR36">36</xref>&#x02013;<xref ref-type="bibr" rid="CR43">43</xref>]. Animal-to-human transmission likely occurs following direct contact with intermediate hosts [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. During the 2003&#x02013;2004 SARS epidemic, 8096 cases and 774 deaths were reported from 26 countries with no cases reported since (Fig. <xref rid="Fig2" ref-type="fig">5.2c</xref>) [<xref ref-type="bibr" rid="CR45">45</xref>]. Human-to-human transmission of SARS-CoV
occurred primarily in healthcare settings with healthcare workers comprising 22% and &#x0003e;40% of reported cases in China and Canada, respectively [<xref ref-type="bibr" rid="CR45">45</xref>]. MERS was first reported in Saudi Arabia in 2012 with &#x0003e;2000 cases and &#x0003e;800 deaths reported from 27 countries through 2018 [<xref ref-type="bibr" rid="CR46">46</xref>]. While most cases have been reported from the Arabian Peninsula, an imported case to South
Korea in 2015 resulted in a large outbreak in multiple healthcare facilities [<xref ref-type="bibr" rid="CR47">47</xref>]. MERS transmission occurs primarily
in healthcare facilities and to a lesser degree within households [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>].</p></sec><sec id="Sec10"><title>Smallpox Eradication</title><p id="Par13">While the only known reservoir forVARV is humans, it has been postulated that the virus emerged from an ancestral rodent-borne poxvirus more than 10,000&#x000a0;years ago [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Numerous smallpox epidemics have occurred throughout recorded history including more than 300 million fatalities during the twentieth century alone [<xref ref-type="bibr" rid="CR51">51</xref>&#x02013;<xref ref-type="bibr" rid="CR53">53</xref>]. Smallpox was eventually eradicated following the implementation of the Smallpox Eradication Program by the WHO from 1966 to 1980 (Fig. <xref rid="Fig2" ref-type="fig">5.2d</xref>) which was facilitated by the absence of a zoonotic reservoir for VARV [<xref ref-type="bibr" rid="CR51">51</xref>].</p></sec></sec><sec id="Sec11"><title>Pathogenesis</title><sec id="Sec12"><title>Influenza Transmission and Mechanisms of Disease</title><p id="Par14">Influenza viruses are transmitted bylarge respiratory droplets by coughing, sneezing, or talking or through contact with infected surfaces [<xref ref-type="bibr" rid="CR54">54</xref>]. Influenza viruses bind to sugar moieties on the surface of airway epithelial cells where early viral replication, propagation, and shedding occur during an average 1&#x02013;2&#x000a0;days of incubationperiod [<xref ref-type="bibr" rid="CR55">55</xref>&#x02013;<xref ref-type="bibr" rid="CR57">57</xref>]. Peak viral replication typically occurs within 4&#x000a0;days of symptom onset and resolves within 7&#x02013;10&#x000a0;days, lasting longer in children and immunocompromised hosts [<xref ref-type="bibr" rid="CR58">58</xref>&#x02013;<xref ref-type="bibr" rid="CR60">60</xref>]. On average one person infects &#x02014;one to two additional people; however, this reproductive number (R<sub>0</sub>) varies by viral strain and social and environmental factors [<xref ref-type="bibr" rid="CR61">61</xref>]. Viral infection impairs the airway mucosal barrier and disrupts the alveolar-capillary membrane contributing to leakage of fluid and inflammatory cells into the alveolar space which impairs gas exchange resulting in hypoxemia [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Bacterial coinfection often complicates severe cases contributing to respiratory failure and death, with <italic>Staphylococcus aureus</italic> and <italic>Streptococcus species</italic> as predominant copathogens [<xref ref-type="bibr" rid="CR64">64</xref>]. Seasonal influenza virus infection is largely limited to the respiratory tract; however, H5 and H7 HPAI viruses have a polybasic cleave site within the hemagglutinin allowing for replication outside of the respiratory tract [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Infectionwith one strain of influenza does not confer complete immunity to other strains or subtypes [<xref ref-type="bibr" rid="CR67">67</xref>].</p></sec><sec id="Sec13"><title>Measles Transmission and Mechanisms of Disease</title><p id="Par15">Measles is among the most highlycontagious respiratory infections, spread by exposure to large respiratory droplets through coughing, sneezing, or talking; by indirect contact with infected surfaces; or by small infectious droplets that can remain suspended in air for up to 2&#x000a0;hours [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]. Respiratory tract dendritic cells, lymphocytes, and alveolar macrophages are early targets of infection where during an average 8- to 12-day incubation period measles replicates and spreads to local lymphatics and respiratory epithelium and then disseminates in blood via infected lymphocytes to epithelial and endothelial cells in most organs [<xref ref-type="bibr" rid="CR69">69</xref>&#x02013;<xref ref-type="bibr" rid="CR71">71</xref>]. The infectious period begins with fever onset and extends for several days after rash appears [<xref ref-type="bibr" rid="CR72">72</xref>]. The estimated R<sub>0</sub> of measles is 9&#x02013;18 dependent upon host susceptibility and social and environmental factors [<xref ref-type="bibr" rid="CR73">73</xref>]. Measles infects and disrupts tissues throughout the body;however, severe disease is primarily due to lower respiratory tract and neurological complications [<xref ref-type="bibr" rid="CR72">72</xref>]. Natural measles infection confers lifelong immunity, and passive transfer of maternal antibodies protects newborns during the early postnatal period [<xref ref-type="bibr" rid="CR74">74</xref>]. Individuals who recover from measles infection are at increasedrisk of secondary infection [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>].</p></sec><sec id="Sec14"><title>SARS- and MERS-CoV Transmission and Mechanisms of Disease</title><p id="Par16">SARS-CoV is transmitted by
large respiratory droplets and by contact with infected surfaces. Epidemiologic data also support small droplet airborne transmission of SARS-CoV although the estimated R<sub>0</sub> of 0.86&#x02013;1.83 argues against this being a predominate route of spread [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. SARS-CoV binds to angiotensin-converting enzyme (ACE)-2 receptors on respiratory epithelial
cells, pneumocytes, and alveolar macrophages resulting in diffuse alveolar damage and respiratory failure [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. SARS is a systemic infection with viremia detected in most cases affecting multiple cell types and organs [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Acute kidney injury is multifactorial with evidence of acute tubule necrosis, vasculitis, and glomerular fibrosis, and central
nervous system manifestations are at least in part attributable to direct infection of neurons resulting in edema and degeneration [<xref ref-type="bibr" rid="CR83">83</xref>].</p><p id="Par17">MERS-CoV is transmitted
by large respiratory droplets and by contact with infected surfaces with an estimated R0 of &#x0003c;1 to &#x0003e;1 outside of versus within healthcare settings, respectively [<xref ref-type="bibr" rid="CR84">84</xref>]. MERS-CoV binds dipeptidyl peptidase 4 (DPP4) on respiratory epithelial cells and pneumocytes where it undergoes productive replication during a 2&#x02013;14&#x000a0;days incubation period [<xref ref-type="bibr" rid="CR16">16</xref>]. Viral shedding from the lower respiratory tract may persist for weeks [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. Viremia, while not documented in all cases, is associated with severe disease and productive infection of DCs, and macrophages is thought to facilitate immune dysregulation [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. DPP4 is broadly expressed on cells outside of the lung; however,
few autopsy data are available to define viral distribution [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR89">89</xref>].</p></sec><sec id="Sec15"><title>Variola Virus Transmission and Mechanisms of Disease</title><p id="Par18">VARV is transmitted primarily by large respiratory droplets and to a lesser degree through contact with contaminated objects such as scabs, bedding, or clothing or by airborne small respiratory droplets [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]. VARV is thought to replicate in airway epithelium and spread to regional lymph nodes [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. VARV replicates within lymph nodes and disseminates via the bloodstream seeding distant sightsincluding skin, spleen, bone marrow, liver, kidney, and other organs [<xref ref-type="bibr" rid="CR94">94</xref>]. Fever manifests following an average 12&#x000a0;days incubation, and rash follows fever by 3&#x02013;4&#x000a0;days, concurrent with high-level viral shedding from oropharyngeal secretions [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. The estimated R<sub>0</sub> of smallpox is between 3.5 and 6 [<xref ref-type="bibr" rid="CR97">97</xref>]. High-level viremia is detected more often with hemorrhagic compared with ordinary type smallpox, although exact mechanisms of organ failure observed in fatal case are not welldefined [<xref ref-type="bibr" rid="CR98">98</xref>&#x02013;<xref ref-type="bibr" rid="CR101">101</xref>].</p></sec></sec><sec id="Sec16"><title>Clinical Findings</title><sec id="Sec17"><title>Influenza Illness and Complications</title><p id="Par19">Influenza infection manifests as acute onset of fever, chills, malaise, headache, and myalgias following an average 1&#x02013;2&#x000a0;days asymptomatic incubation period [<xref ref-type="bibr" rid="CR9">9</xref>]. Most infections are self-limited resolving within 1&#x02013;2&#x000a0;weeks. Upper or lower airway complications include otitis media, sinusitis, bronchitis, and pneumonia with or without bacterial coinfection [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. Risk factors for severe infection include age &#x0003e;65&#x000a0;years or &#x0003c;5&#x000a0;years; pregnancy; preexisting respiratory, cardiac, neurologic, or metabolic conditions; immunosuppression; andobesity. Progressive lethargy and shortness of breath, typically within 5&#x000a0;days of symptom onset, suggest development of lower respiratory tract complications which may rapidly progress to respiratory failure and death in severe cases [<xref ref-type="bibr" rid="CR64">64</xref>]. Pneumonia due to influenza infection alone versus influenza and bacterialcoinfection cannot be reliably distinguished by clinical or radiological grounds, and so a high index of suspicion is needed. Influenza complications outside of the respiratory tract include exacerbation of underlying heart disease including ischemic heart disease and heart failure, myocarditis, encephalopathy,and encephalitis [<xref ref-type="bibr" rid="CR103">103</xref>].</p></sec><sec id="Sec18"><title>Measles Illness and Complications</title><p id="Par20">Measles infectionmanifests by acute onset fever, coryza, conjunctivitis, and cough [<xref ref-type="bibr" rid="CR10">10</xref>]. Small white papules, Koplik spots, appear on the buccal mucosa within 3&#x000a0;days of fever onset, followed by development of diffuse maculopapular rash 1 or 2&#x000a0;days later. Diarrhea commonly begins shortly following rash onset and may result in dehydration. Symptoms typically resolve within 7&#x000a0;days of fever onset in self-limited illness. Groups at increased risk for measles complications include malnourished infants and those with vitamin A deficiency, adults &#x0003e;20&#x000a0;years old, and immunocompromised individuals [<xref ref-type="bibr" rid="CR72">72</xref>]. Respiratory complications include otitis media, laryngotracheobronchitis (croup), and pneumonia. Pneumonia, often complicated by bacterial coinfection, is the most common severe complication of measles contributing to respiratory failure and death [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR104">104</xref>]. Predominantbacterial copathogens include <italic>Streptococcus pneumonia</italic>, <italic>Staphylococcus aureus</italic>, and <italic>Haemophilus influenzae</italic>.</p><p id="Par21">Three rare but severe neurologic complications occur [<xref ref-type="bibr" rid="CR105">105</xref>]. Acute disseminated encephalomyelitis (ADEM) is a demyelinating autoimmune process that occurs within weeks of acute illness in approximately 1 in 1000 cases. ADEM is characterized by fevers, seizures, and neurologic deficits. Measles inclusion body encephalitis is a progressive lethal brain infection occurring within months of acute illness primarily among individuals with impaired cellular immunity. Subacute sclerosing panencephalitis (SSPE) occurs 5&#x02013;10&#x000a0;years following initial infection resulting in seizures and cognitive and motor decline resulting in death. SSPE affects an estimated 1 in 10,000 infants under 1&#x000a0;year of age and is attributed to host responses to defective viral particleproduction in the brain.</p></sec><sec id="Sec19"><title>SARS and MERS Illness and Complications</title><p id="Par22">Following an average 5-day
incubation period, SARS-CoV infection presents with fevers, chills, dry cough, headache, malaise, and dyspnea commonly followed by watery diarrhea [<xref ref-type="bibr" rid="CR106">106</xref>&#x02013;<xref ref-type="bibr" rid="CR108">108</xref>]. Age &#x0003e;60&#x000a0;years and pregnancy are associated with severe disease manifested by progressive respiratory failure within 2&#x000a0;weeks of illness onset [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. Common laboratory features of SARS included lymphopenia, thrombocytopenia, abnormal coagulation parameters, and elevated lactate dehydrogenase, alanine aminotransferase, and creatine kinase levels [<xref ref-type="bibr" rid="CR110">110</xref>&#x02013;<xref ref-type="bibr" rid="CR112">112</xref>]. Acute kidney injury and
proteinuria were observed in 7% and 84% of patients, respectively [<xref ref-type="bibr" rid="CR113">113</xref>].</p><p id="Par23">Initial symptoms of MERS-CoV infection include fever, chills, cough, shortness of breath, myalgia, and malaise following a mean
incubation period of 5&#x000a0;days [<xref ref-type="bibr" rid="CR114">114</xref>]. Gastrointestinal symptoms, including vomiting and diarrhea, occur in one-third of patients [<xref ref-type="bibr" rid="CR115">115</xref>&#x02013;<xref ref-type="bibr" rid="CR118">118</xref>]. The median times from symptom onset to hospitalization, ICU admission, and death are 4, 5, and 12&#x000a0;days, respectively [<xref ref-type="bibr" rid="CR118">118</xref>]. MERS patients present with a rapidly progressing pneumonia requiring mechanical ventilation and additional
organ support with the first week of illness [<xref ref-type="bibr" rid="CR109">109</xref>]. Severe disease has been linked to comorbidities including diabetes mellitus (68%), chronic renal disease (49%), hypertension (34%), chronic cardiac disease (28%), chronic pulmonary disease (26%), and obesity (17%) [<xref ref-type="bibr" rid="CR114">114</xref>]. The median age of those with confirmed MERS is 50&#x000a0;years with a male-to-female ratio of 3.3:1 [<xref ref-type="bibr" rid="CR114">114</xref>]. Laboratory abnormalities include lymphopenia, leukopenia,
thrombocytopenia, elevated serum creatinine levels consistent with acute kidney injury, and elevated liver enzymes [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR120">120</xref>]. High lactate levels and consumptive coagulopathy have also been reported [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR121">121</xref>]. Chest radiographic abnormalities are due to viral pneumonitis with or without secondary bacterial pneumonia, and acute kidney injury
occurs in up to 43% of patients [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR122">122</xref>&#x02013;<xref ref-type="bibr" rid="CR124">124</xref>].</p></sec><sec id="Sec20"><title>Smallpox Illness and Complications</title><p id="Par24">As the smallpox disease coursewas related to the clinical presentation of disease, Rao proposed a clinical classification system [<xref ref-type="bibr" rid="CR125">125</xref>] that was later adopted by the WHO in 1972 [<xref ref-type="bibr" rid="CR51">51</xref>]. was the most common clinical type of smallpox. The incubation period was 7&#x02013;19&#x000a0;days and was followed by fever onset (38.5&#x02013;40.5&#x000a0;&#x000b0;C), headaches, backaches, vomiting, and diarrhea [<xref ref-type="bibr" rid="CR51">51</xref>]. Lesions first appeared on mucous membranes (including the tongue, palate, and pharynx) ~1&#x000a0;day prior to macular rash development, where lesions began on the face followed by proximal regions of the extremities, the trunk, and the distal extremities. Lesion development followed a centrifugal dispersionpattern, typically most dense on the face, with papules appearing within 2&#x000a0;days of macular rash development. Papules became vesicular ~2&#x02013;4&#x000a0;days later followed by a pustular stage (5&#x02013;7&#x000a0;days postrash) that peaked ~10&#x000a0;days postrash. Pustule resolution quickly followed and was accompanied by lesion flattening, fluid reabsorption, hardening, and scab formation (14&#x02013;21&#x000a0;days postrash). Rao proposed for ordinary type smallpox to be further subdivided based on the macular rash pattern [<xref ref-type="bibr" rid="CR125">125</xref>]. These included <italic>discrete ordinary-type smallpox</italic>
, characterized by discrete skin lesions; , where pustular skin lesions were confluent on the face and extremities; and , where skin lesions were confluent on the face but disparate over the rest of the body. Modified-type smallpox, where lesions were less numerous than in ordinary-type smallpox, was primarily associated with vaccinated individuals and had an accelerated nonfatal disease course [<xref ref-type="bibr" rid="CR125">125</xref>]. Flat-type and hemorrhagic-type smallpox were the most lethalforms of the disease but were also very rare (~7% and 3% of patients, respectively) [<xref ref-type="bibr" rid="CR51">51</xref>]. Flat-type smallpox had high CFRs in both unvaccinated and vaccinated patients (97% and 67%, respectively). Hemorrhagic-type smallpox was nearly 100% fatal in both vaccinated and unvaccinated individuals, and death normally came prior to macular rash development. The clinical symptoms of flat-type smallpox were more severe during the prodromal period and did not subside. Skin lesions were flat and often black or dark purple. Respiratory complications were common and patients were febrile throughout disease. Death typically occurred 8&#x02013;12&#x000a0;days post-fever onset. Hemorrhagic-type smallpox could be divided into early and late hemorrhagic-type smallpox. <italic>The early form</italic> was characterized by hemorrhage (primarily subconjunctival) early in the disease course. Generalized erythema,petechiae, and ecchymosis within 2&#x000a0;days of fever and flat matter lesions formed across the entire body surface. Lesions turned purple by day 4 with death by day 6 as a result of cardiac and pulmonary complications. In the late form, hemorrhages occurred following rash development and death followed between8 and 10&#x000a0;days post-fever onset.</p></sec></sec><sec id="Sec21"><title>Diagnosis</title><sec id="Sec22"><title>Influenza: Infection Control and Confirmatory Testing</title><p id="Par25">In healthcare settings, patients under evaluation for influenza should be isolated, and standard, droplet, and contact precautions should be implemented [<xref ref-type="bibr" rid="CR126">126</xref>]. Traditional antigen-based rapid diagnostic assays (RDAs) for influenza lack sensitivity and cannot be relied upon to rule out infection [<xref ref-type="bibr" rid="CR26">26</xref>]. Newer antigen-based RDAs that employ a digital scan of the test strip, and molecular assays that employisothermal amplification technology have improved sensitivity and specificity that more closely approximates highly sensitive and specific reverse transcriptase polymerase chain reaction (RT-PCR)-based assays [<xref ref-type="bibr" rid="CR127">127</xref>]. Acceptable sample types for influenza testing include nasopharyngeal swab or wash and bronchoalveolar lavage specimens. Individuals suspected of zoonotic influenza infection should have case evaluation and specimen testing coordinated through local or state public health authorities.</p></sec><sec id="Sec23"><title>Measles: Infection Control and Confirmatory Testing</title><p id="Par26">Measles should be consideredin patients without preexisting immunity and a compatible febrile rash illness. Travel to a region with ongoing measles transmission or exposure to other individuals with a febrile rash illness should raise suspicion. Patients under evaluation for measles require isolation and implementation of standard, airborne, and contact precautions. Local or state health authorities should be contacted within 24&#x000a0;hours to assist with confirmatory testing, case finding, and infection control. Measles is typically confirmed by measles-specific IgM serology or detection of measles RNA in a nasopharyngeal, throat, or urine specimen by RT-PCR [<xref ref-type="bibr" rid="CR10">10</xref>]. A fourfold or greater rise in measles IgG titers between acute and convalescent samples tested 2 or more weeks apart can assist with diagnostic uncertainty. Virus can also be cultured from respiratory, blood, and urine specimens in appropriate public health laboratories.</p></sec><sec id="Sec24"><title>SARS and MERS: Infection Control and Confirmatory Testing</title><p id="Par27">While SARS is no longer
circulating, MERS should be suspected in individuals with a compatible febrile illness and an epidemiological risk factor [<xref ref-type="bibr" rid="CR128">128</xref>]. Risk factors include travel to the Arabian Peninsula or contact with a confirmed or suspected case within 14&#x000a0;days of symptom onset. Patients under evaluation for MERS require isolation and implementation of standard, airborne, and contact precautions. Confirmatory testing and infection control should be coordinated
through local or state health authorities. MERS may be confirmed in designated public health laboratories by RT-PCR testing of lower respiratory tract specimens [<xref ref-type="bibr" rid="CR129">129</xref>]. Multiple other specimen types including upper respiratory tract samples, serum, and stool should also be collected for testing. Serologic testing can
be used to evaluate for suspected infection among individuals no longer shedding virus [<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>].</p></sec><sec id="Sec25"><title>Smallpox: Infection Control and Confirmatory Testing</title><p id="Par28">Smallpox has not been observedin over 40&#x000a0;years; however, concerns remain for use as a bioweapon. Major and minor criteria have been established to assist clinicians in recognition of smallpox [<xref ref-type="bibr" rid="CR131">131</xref>]. Individuals under evaluation should be isolated, and standard, airborne, and contact precautions should be implemented. Local or state health authorities should be contacted to assist with confirmatory testing and public health interventions. PCR identification of variola DNA or isolation of the virus from a clinical specimen isrequired to confirm a diagnosis in specialized high-containment laboratories.</p></sec></sec><sec id="Sec26"><title>Clinical Management</title><sec id="Sec27"><title>Influenza Prevention and Treatment</title><p id="Par29">Annual seasonal influenza vaccination is recommended in the United States for all individuals aged 6&#x000a0;months or older and has been associated with decreased risk of pneumonia and death, particularly among high-risk groups [<xref ref-type="bibr" rid="CR132">132</xref>&#x02013;<xref ref-type="bibr" rid="CR134">134</xref>]. Seasonal influenza vaccination does not provide protection against novel strains. Consequently, efforts are underway to develop a vaccine that would protect against most or all influenza strains [<xref ref-type="bibr" rid="CR135">135</xref>]. Three classes of drugs are licensed for the treatment of influenza in the United States [<xref ref-type="bibr" rid="CR136">136</xref>]. Adamantanes, including amantadine and rimantadine,are not currently recommended given resistance of circulating seasonal strains. Baloxavir morboxil, a cap-dependent endonuclease inhibitor, was recently approved for the treatment of uncomplicated influenza [<xref ref-type="bibr" rid="CR137">137</xref>]. Neuraminidase inhibitors (NAI) include oral oseltamivir, inhaled zanamivir, and intravenous peramivir. Prophylactic use of NAIs is recommended in unvaccinated individuals with risk factors for severe disease and during institutional outbreaks to limit spread. Therapeutic use is recommended for individuals with suspected or confirmed influenza that have developed or are at high risk for influenza complications [<xref ref-type="bibr" rid="CR26">26</xref>]. Influenza complications,including respiratory and multiorgan failure, are managed with supportive care. Bacterial coinfection should be considered and empirically treated early pending results of microbiologic testing among severe cases.</p></sec><sec id="Sec28"><title>Measles Prevention and Treatment</title><p id="Par30">Measles can be effectively prevented through vaccination, typically given in combination with vaccines for rubella (MR), mumps (MMR), or varicella (MMR-V). WHO recommends the first dose of measles vaccine be administered at 9 or 12&#x000a0;months of age in high and low prevalence settings, respectively [<xref ref-type="bibr" rid="CR138">138</xref>]. A second dose should be administered after a minimum of 4-week interval. Nonimmune individuals that have been exposed to measles should receive post-exposure prophylaxis with MMR or immunoglobulin within 72&#x000a0;hours or 6&#x000a0;days, respectively, although not concurrently [<xref ref-type="bibr" rid="CR139">139</xref>]. Clinical management of patients with measles consists of fluid, electrolyte, and nutritional support and early recognition and treatment of bacterial coinfection [<xref ref-type="bibr" rid="CR10">10</xref>]. Two doses of vitamin A inchildren under 2&#x000a0;years have been associated with reduced risk of pneumonia and death [<xref ref-type="bibr" rid="CR140">140</xref>]. WHO recommends administering 200,000 IU of vitamin A daily for 2&#x000a0;days in children aged 1&#x000a0;year and older, with reduced dosingin younger infants [<xref ref-type="bibr" rid="CR141">141</xref>].</p></sec><sec id="Sec29"><title>SARS and MERS Treatment</title><p id="Par31">There are currently
no licensed therapeutics or vaccines for SARS or MERS. Consequently, supportive care is the mainstay of treatment [<xref ref-type="bibr" rid="CR142">142</xref>]. Renal replacement therapy is frequently required in severe illness [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR143">143</xref>, <xref ref-type="bibr" rid="CR144">144</xref>]. Empiric antibiotics are often administered given potential for secondary bacterial infection. Ribavirin and pegylated interferon alpha 2b have been administered to MERS patients, although effectiveness data is lacking [<xref ref-type="bibr" rid="CR144">144</xref>]. Aerosol-generating procedures including endotracheal intubation are associated with increased risk of healthcare worker infection necessitating strict adherence to infection control measures,
including use of eye protection in addition to standard, airborne, and contact precautions [<xref ref-type="bibr" rid="CR145">145</xref>].</p></sec><sec id="Sec30"><title>Smallpox Prevention and Treatment</title><p id="Par32">While routine smallpox vaccinationceased at the end of the smallpox eradication program, it is still employed for those at increased risk for exposure. First-generation vaccines comprise a significant proportion of both the US national and global vaccine stockpiles [<xref ref-type="bibr" rid="CR146">146</xref>]. However, first-generation vaccines carry high risk of adverse events due to use of replication-competent VACV and potential manufacturing contaminants. Second-generation smallpox vaccines have reduced concerns for contaminants and are expected to have similar protective efficacy as first-generation vaccines. ACAM2000&#x000ae; has garnered US Food and Drug Administration licensure for vaccination of those at high risk for exposure and is part of the US strategic national stockpile [<xref ref-type="bibr" rid="CR147">147</xref>]. ACAM2000&#x000ae; and the Lister-derived vaccines RIVM and Elstree-BN also contribute to the global stockpile. IMVAMUNE (MVA), a third-generation vaccine, is licensed in Europe and Canada and is part of the US national stockpile. Passive immunization with VIG has been employed to treat complications of vaccinations [<xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR149">149</xref>]. There has also been increasing interest in the development and licensure of small molecule antivirals for treatment of <italic>Orthopoxvirus</italic> infections. CMX001 (brincidofovir), a DNA synthesis inhibitor, has demonstrated protection against lethal VARV in nonhuman primates [<xref ref-type="bibr" rid="CR150">150</xref>] and has been granted ophan drug designation while also being included in the US Strategic National Stockpile. ST-246 (tecovirimat), which inhibits viral egress, has potent (IC50 &#x0003c; 0.010&#x000a0;&#x003bc;M) and selective (CC50 &#x0003e; 40&#x000a0;mM) inhibitory activities against multiple orthopoxvirues [<xref ref-type="bibr" rid="CR151">151</xref>], is the only antipoxvirus therapeutic that has been granted approval in the US and has been added to the Strategic National Stockpile.</p></sec></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Types of influenza viruses. [cited 2019 March 1]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/about/viruses/types.htm">https://www.cdc.gov/flu/about/viruses/types.htm</ext-link>.</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name></person-group><source>Fields virology</source><year>2013</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Wolters Kluwer/Lippincott Williams &#x00026; Wilkins Health</publisher-name></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>SK</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>McDaniel</surname><given-names>CJ</given-names></name><name><surname>Gray</surname><given-names>GC</given-names></name><name><surname>Lednicky</surname><given-names>JA</given-names></name></person-group><article-title>Serologic evidence of exposure to influenza D virus among persons with occupational contact with cattle</article-title><source>J Clin Virol</source><year>2016</year><volume>81</volume><fpage>31</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2016.05.017</pub-id><?supplied-pmid 27294672?><pub-id pub-id-type="pmid">27294672</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hause</surname><given-names>BM</given-names></name><name><surname>Collin</surname><given-names>EA</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Sheng</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Nelson</surname><given-names>EA</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family</article-title><source>MBio</source><year>2014</year><volume>5</volume><fpage>e00031-00014</fpage><pub-id pub-id-type="doi">10.1128/mBio.00031-14</pub-id><pub-id pub-id-type="pmid">24595369</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name></person-group><article-title>Avian influenza virus surveillance and wild birds: past and present</article-title><source>Avian Dis</source><year>2010</year><volume>54</volume><fpage>394</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1637/8703-031609-Review.1</pub-id><?supplied-pmid 20521668?><pub-id pub-id-type="pmid">20521668</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Rivailler</surname><given-names>P</given-names></name><name><surname>Conrardy</surname><given-names>C</given-names></name><name><surname>Castillo</surname><given-names>DA</given-names></name><name><surname>Chen</surname><given-names>LM</given-names></name><name><surname>Recuenco</surname><given-names>S</given-names></name><name><surname>Ellison</surname><given-names>JA</given-names></name><name><surname>Davis</surname><given-names>CT</given-names></name><name><surname>York</surname><given-names>IA</given-names></name><name><surname>Turmelle</surname><given-names>AS</given-names></name><name><surname>Moran</surname><given-names>D</given-names></name><name><surname>Rogers</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Weil</surname><given-names>MR</given-names></name><name><surname>Tang</surname><given-names>K</given-names></name><name><surname>Rowe</surname><given-names>LA</given-names></name><name><surname>Sammons</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Frace</surname><given-names>M</given-names></name><name><surname>Lindblade</surname><given-names>KA</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Rupprecht</surname><given-names>CE</given-names></name><name><surname>Donis</surname><given-names>RO</given-names></name></person-group><article-title>A distinct lineage of influenza A virus from bats</article-title><source>Proc Natl Acad Sci U S A</source><year>2012</year><volume>109</volume><fpage>4269</fpage><lpage>4274</lpage><pub-id pub-id-type="doi">10.1073/pnas.1116200109</pub-id><?supplied-pmid 22371588?><pub-id pub-id-type="pmid">22371588</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Bourgeois</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Recuenco</surname><given-names>S</given-names></name><name><surname>Gomez</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>LM</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Dreyfus</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>McBride</surname><given-names>R</given-names></name><name><surname>Carney</surname><given-names>PJ</given-names></name><name><surname>Gilbert</surname><given-names>AT</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Davis</surname><given-names>CT</given-names></name><name><surname>Paulson</surname><given-names>JC</given-names></name><name><surname>Stevens</surname><given-names>J</given-names></name><name><surname>Rupprecht</surname><given-names>CE</given-names></name><name><surname>Holmes</surname><given-names>EC</given-names></name><name><surname>Wilson</surname><given-names>IA</given-names></name><name><surname>Donis</surname><given-names>RO</given-names></name></person-group><article-title>New world bats harbor diverse influenza A viruses</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><fpage>e1003657</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1003657</pub-id><?supplied-pmid 24130481?><pub-id pub-id-type="pmid">24130481</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull World Health Organ. 1980;58:585&#x02013;91.</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krammer</surname><given-names>F</given-names></name><name><surname>Smith</surname><given-names>GJD</given-names></name><name><surname>Fouchier</surname><given-names>RAM</given-names></name><name><surname>Peiris</surname><given-names>M</given-names></name><name><surname>Kedzierska</surname><given-names>K</given-names></name><name><surname>Doherty</surname><given-names>PC</given-names></name><name><surname>Palese</surname><given-names>P</given-names></name><name><surname>Shaw</surname><given-names>ML</given-names></name><name><surname>Treanor</surname><given-names>J</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Garcia-Sastre</surname><given-names>A</given-names></name></person-group><article-title>Influenza</article-title><source>Nat Rev Dis Primers</source><year>2018</year><volume>4</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1038/s41572-018-0002-y</pub-id><?supplied-pmid 29955068?><pub-id pub-id-type="pmid">29955068</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>WJ</given-names></name></person-group><article-title>Measles</article-title><source>Lancet</source><year>2017</year><volume>390</volume><fpage>2490</fpage><lpage>2502</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)31463-0</pub-id><?supplied-pmid 28673424?><pub-id pub-id-type="pmid">28673424</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Horikami</surname><given-names>SM</given-names></name><name><surname>Moyer</surname><given-names>SA</given-names></name></person-group><source>Structure, transcription, and replication of measles virus</source><year>1995</year><publisher-loc>Berlin, Heidelberg</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>AR</given-names></name><name><surname>Perlman</surname><given-names>S</given-names></name></person-group><article-title>Coronaviruses: an overview of their replication and pathogenesis</article-title><source>Methods Mol Biol</source><year>2015</year><volume>1282</volume><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-2438-7_1</pub-id><?supplied-pmid 25720466?><pub-id pub-id-type="pmid">25720466</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jevsnik</surname><given-names>M</given-names></name><name><surname>Ursic</surname><given-names>T</given-names></name><name><surname>Zigon</surname><given-names>N</given-names></name><name><surname>Lusa</surname><given-names>L</given-names></name><name><surname>Krivec</surname><given-names>U</given-names></name><name><surname>Petrovec</surname><given-names>M</given-names></name></person-group><article-title>Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease</article-title><source>BMC Infect Dis</source><year>2012</year><volume>12</volume><fpage>365</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-12-365</pub-id><?supplied-pmid 23256846?><pub-id pub-id-type="pmid">23256846</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Wit</surname><given-names>E</given-names></name><name><surname>van Doremalen</surname><given-names>N</given-names></name><name><surname>Falzarano</surname><given-names>D</given-names></name><name><surname>Munster</surname><given-names>VJ</given-names></name></person-group><article-title>SARS and MERS: recent insights into emerging coronaviruses</article-title><source>Nat Rev Microbiol</source><year>2016</year><volume>14</volume><fpage>523</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2016.81</pub-id><?supplied-pmid 27344959?><pub-id pub-id-type="pmid">27344959</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>RL</given-names></name><name><surname>Donaldson</surname><given-names>EF</given-names></name><name><surname>Baric</surname><given-names>RS</given-names></name></person-group><article-title>A decade after SARS: strategies for controlling emerging coronaviruses</article-title><source>Nat Rev Microbiol</source><year>2013</year><volume>11</volume><fpage>836</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3143</pub-id><?supplied-pmid 24217413?><pub-id pub-id-type="pmid">24217413</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raj</surname><given-names>VS</given-names></name><name><surname>Mou</surname><given-names>H</given-names></name><name><surname>Smits</surname><given-names>SL</given-names></name><name><surname>Dekkers</surname><given-names>DH</given-names></name><name><surname>Muller</surname><given-names>MA</given-names></name><name><surname>Dijkman</surname><given-names>R</given-names></name><name><surname>Muth</surname><given-names>D</given-names></name><name><surname>Demmers</surname><given-names>JA</given-names></name><name><surname>Zaki</surname><given-names>A</given-names></name><name><surname>Fouchier</surname><given-names>RA</given-names></name><name><surname>Thiel</surname><given-names>V</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Rottier</surname><given-names>PJ</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><name><surname>Haagmans</surname><given-names>BL</given-names></name></person-group><article-title>Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC</article-title><source>Nature</source><year>2013</year><volume>495</volume><fpage>251</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1038/nature12005</pub-id><?supplied-pmid 23486063?><pub-id pub-id-type="pmid">23486063</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Moore</surname><given-names>MJ</given-names></name><name><surname>Vasilieva</surname><given-names>N</given-names></name><name><surname>Sui</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>SK</given-names></name><name><surname>Berne</surname><given-names>MA</given-names></name><name><surname>Somasundaran</surname><given-names>M</given-names></name><name><surname>Sullivan</surname><given-names>JL</given-names></name><name><surname>Luzuriaga</surname><given-names>K</given-names></name><name><surname>Greenough</surname><given-names>TC</given-names></name><name><surname>Choe</surname><given-names>H</given-names></name><name><surname>Farzan</surname><given-names>M</given-names></name></person-group><article-title>Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus</article-title><source>Nature</source><year>2003</year><volume>426</volume><fpage>450</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1038/nature02145</pub-id><?supplied-pmid 14647384?><pub-id pub-id-type="pmid">14647384</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diven</surname><given-names>DG</given-names></name></person-group><article-title>An overview of poxviruses</article-title><source>J Am Acad Dermatol</source><year>2001</year><volume>44</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1067/mjd.2001.109302</pub-id><?supplied-pmid 11148468?><pub-id pub-id-type="pmid">11148468</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buller</surname><given-names>RM</given-names></name><name><surname>Palumbo</surname><given-names>GJ</given-names></name></person-group><article-title>Poxvirus pathogenesis</article-title><source>Microbiol Rev</source><year>1991</year><volume>55</volume><fpage>80</fpage><lpage>122</lpage><?supplied-pmid 1851533?><pub-id pub-id-type="pmid">1851533</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>SC</given-names></name><name><surname>Alberts</surname><given-names>B</given-names></name><name><surname>Ehrenfeld</surname><given-names>E</given-names></name><name><surname>Enquist</surname><given-names>L</given-names></name><name><surname>Fineberg</surname><given-names>H</given-names></name><name><surname>McKnight</surname><given-names>SL</given-names></name><name><surname>Moss</surname><given-names>B</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>M</given-names></name><name><surname>Ploegh</surname><given-names>H</given-names></name><name><surname>Schmid</surname><given-names>SL</given-names></name><name><surname>Walter</surname><given-names>KP</given-names></name><name><surname>Theriot</surname><given-names>J</given-names></name></person-group><article-title>Discovery of antivirals against smallpox</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>11178</fpage><lpage>11192</lpage><pub-id pub-id-type="doi">10.1073/pnas.0403600101</pub-id><?supplied-pmid 15249657?><pub-id pub-id-type="pmid">15249657</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">World Health Organization. Avian influenza: assessing the pandemic threat. [cited 2019 March 11]. Available from: <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/68985/WHO_CDS_2005.29.pdf?sequence=1">https://apps.who.int/iris/bitstream/handle/10665/68985/WHO_CDS_2005.29.pdf?sequence=1</ext-link>.</mixed-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Wardrop</surname><given-names>NA</given-names></name><name><surname>Gilbert</surname><given-names>M</given-names></name><name><surname>Tsang</surname><given-names>TK</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Liao</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Horby</surname><given-names>PW</given-names></name><name><surname>Farrar</surname><given-names>JJ</given-names></name><name><surname>Gao</surname><given-names>GF</given-names></name><name><surname>Tatem</surname><given-names>AJ</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><article-title>Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997&#x02013;2015: a systematic review of individual case data</article-title><source>Lancet Infect Dis</source><year>2016</year><volume>16</volume><fpage>e108</fpage><lpage>e118</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(16)00153-5</pub-id><?supplied-pmid 27211899?><pub-id pub-id-type="pmid">27211899</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Xiang</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Meng</surname><given-names>L</given-names></name><name><surname>Hong</surname><given-names>Z</given-names></name><name><surname>Tu</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>T</given-names></name><name><surname>Zou</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Chai</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Pang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Uyeki</surname><given-names>TM</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name></person-group><article-title>Epidemiology of human infections with avian influenza A(H7N9) virus in China</article-title><source>N Engl J Med</source><year>2014</year><volume>370</volume><fpage>520</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1304617</pub-id><?supplied-pmid 23614499?><pub-id pub-id-type="pmid">23614499</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jhung</surname><given-names>MA</given-names></name><name><surname>Nelson</surname><given-names>DI</given-names></name><collab>Centers for Disease Control and Prevention (CDC)</collab></person-group><article-title>Outbreaks of avian influenza A (H5N2), (H5N8), and (H5N1) among birds--United States, December 2014-January 2015</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2015</year><volume>64</volume><fpage>111</fpage><?supplied-pmid 25654614?><pub-id pub-id-type="pmid">25654614</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention (CDC)</collab></person-group><article-title>Influenza A (H3N2) variant virus-related hospitalizations: Ohio, 2012</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2012</year><volume>61</volume><fpage>764</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">23013722</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paules</surname><given-names>C</given-names></name><name><surname>Subbarao</surname><given-names>K</given-names></name></person-group><article-title>Influenza</article-title><source>Lancet</source><year>2017</year><volume>390</volume><fpage>697</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)30129-0</pub-id><?supplied-pmid 28302313?><pub-id pub-id-type="pmid">28302313</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Estimated influenza illnesses, medical visits, hospitalizations, and death in the United States&#x000a0;&#x02014; 2017&#x02013;2018 influenza season. [cited 2019 March 11]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/about/burden/2017-2018.htm#References">https://www.cdc.gov/flu/about/burden/2017-2018.htm#References</ext-link>.</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>JK</given-names></name><name><surname>Morens</surname><given-names>DM</given-names></name></person-group><article-title>1918 influenza: the mother of all pandemics</article-title><source>Emerg Infect Dis</source><year>2006</year><volume>12</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.3201/eid1209.05-0979</pub-id><?supplied-pmid 16494711?><pub-id pub-id-type="pmid">16494711</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">World Health Organization. Global influenza surveillance and response system (GISRS). <ext-link ext-link-type="uri" xlink:href="https://www.who.int/influenza/gisrs_laboratory/en/">https://www.who.int/influenza/gisrs_laboratory/en/</ext-link>. Accessed 19 Apr 2019.</mixed-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>WJ</given-names></name><name><surname>Strebel</surname><given-names>P</given-names></name></person-group><article-title>Biological feasibility of measles eradication</article-title><source>J Infect Dis</source><year>2011</year><volume>204</volume><issue>Suppl 1</issue><fpage>S47</fpage><lpage>S53</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir065</pub-id><?supplied-pmid 21666201?><pub-id pub-id-type="pmid">21666201</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Laws</surname><given-names>RL</given-names></name><name><surname>Steulet</surname><given-names>C</given-names></name><name><surname>Dumolard</surname><given-names>L</given-names></name><name><surname>Mulders</surname><given-names>MN</given-names></name><name><surname>Kretsinger</surname><given-names>K</given-names></name><name><surname>Alexander</surname><given-names>JP</given-names></name><name><surname>Rota</surname><given-names>PA</given-names></name><name><surname>Goodson</surname><given-names>JL</given-names></name></person-group><article-title>Progress toward regional measles elimination&#x000a0;&#x02013; worldwide, 2000&#x02013;2017</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2018</year><volume>67</volume><fpage>1323</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6747a6</pub-id><?supplied-pmid 30496160?><pub-id pub-id-type="pmid">30496160</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornton</surname><given-names>J</given-names></name></person-group><article-title>Measles cases in Europe tripled from 2017 to 2018</article-title><source>BMJ</source><year>2019</year><volume>364</volume><fpage>l634</fpage><pub-id pub-id-type="doi">10.1136/bmj.l634</pub-id><?supplied-pmid 30733215?><pub-id pub-id-type="pmid">30733215</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gastanaduy</surname><given-names>PA</given-names></name><name><surname>Budd</surname><given-names>J</given-names></name><name><surname>Fisher</surname><given-names>N</given-names></name><name><surname>Redd</surname><given-names>SB</given-names></name><name><surname>Fletcher</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>DJ</surname><given-names>MF</given-names><suffix>3rd</suffix></name><name><surname>Rota</surname><given-names>J</given-names></name><name><surname>Rota</surname><given-names>PA</given-names></name><name><surname>Hickman</surname><given-names>C</given-names></name><name><surname>Fowler</surname><given-names>B</given-names></name><name><surname>Tatham</surname><given-names>L</given-names></name><name><surname>Wallace</surname><given-names>GS</given-names></name><name><surname>de Fijter</surname><given-names>S</given-names></name><name><surname>Parker Fiebelkorn</surname><given-names>A</given-names></name><name><surname>DiOrio</surname><given-names>M</given-names></name></person-group><article-title>A measles outbreak in an underimmunized Amish Community in Ohio</article-title><source>N Engl J Med</source><year>2016</year><volume>375</volume><fpage>1343</fpage><lpage>1354</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1602295</pub-id><?supplied-pmid 27705270?><pub-id pub-id-type="pmid">27705270</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>MK</given-names></name><name><surname>Gacic-Dobo</surname><given-names>M</given-names></name><name><surname>Strebel</surname><given-names>PM</given-names></name><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Mulders</surname><given-names>MN</given-names></name><name><surname>Okwo-Bele</surname><given-names>JM</given-names></name><name><surname>Dumolard</surname><given-names>L</given-names></name><name><surname>Rota</surname><given-names>PA</given-names></name><name><surname>Kretsinger</surname><given-names>K</given-names></name><name><surname>Goodson</surname><given-names>JL</given-names></name></person-group><article-title>Progress toward regional measles elimination&#x000a0;&#x02013; worldwide, 2000&#x02013;2015</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2016</year><volume>65</volume><fpage>1228</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6544a6</pub-id><?supplied-pmid 27832050?><pub-id pub-id-type="pmid">27832050</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallinga</surname><given-names>J</given-names></name><name><surname>Heijne</surname><given-names>JC</given-names></name><name><surname>Kretzschmar</surname><given-names>M</given-names></name></person-group><article-title>A measles epidemic threshold in a highly vaccinated population</article-title><source>PLoS Med</source><year>2005</year><volume>2</volume><fpage>e316</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0020316</pub-id><?supplied-pmid 16218769?><pub-id pub-id-type="pmid">16218769</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haagmans</surname><given-names>BL</given-names></name><name><surname>Al Dhahiry</surname><given-names>SH</given-names></name><name><surname>Reusken</surname><given-names>CB</given-names></name><name><surname>Raj</surname><given-names>VS</given-names></name><name><surname>Galiano</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>R</given-names></name><name><surname>Godeke</surname><given-names>GJ</given-names></name><name><surname>Jonges</surname><given-names>M</given-names></name><name><surname>Farag</surname><given-names>E</given-names></name><name><surname>Diab</surname><given-names>A</given-names></name><name><surname>Ghobashy</surname><given-names>H</given-names></name><name><surname>Alhajri</surname><given-names>F</given-names></name><name><surname>Al-Thani</surname><given-names>M</given-names></name><name><surname>Al-Marri</surname><given-names>SA</given-names></name><name><surname>Al Romaihi</surname><given-names>HE</given-names></name><name><surname>Al Khal</surname><given-names>A</given-names></name><name><surname>Bermingham</surname><given-names>A</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>AlHajri</surname><given-names>MM</given-names></name><name><surname>Koopmans</surname><given-names>MP</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation</article-title><source>Lancet Infect Dis</source><year>2014</year><volume>14</volume><fpage>140</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(13)70690-X</pub-id><?supplied-pmid 24355866?><pub-id pub-id-type="pmid">24355866</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reusken</surname><given-names>CB</given-names></name><name><surname>Haagmans</surname><given-names>BL</given-names></name><name><surname>Muller</surname><given-names>MA</given-names></name><name><surname>Gutierrez</surname><given-names>C</given-names></name><name><surname>Godeke</surname><given-names>GJ</given-names></name><name><surname>Meyer</surname><given-names>B</given-names></name><name><surname>Muth</surname><given-names>D</given-names></name><name><surname>Raj</surname><given-names>VS</given-names></name><name><surname>Smits-De Vries</surname><given-names>L</given-names></name><name><surname>Corman</surname><given-names>VM</given-names></name><name><surname>Drexler</surname><given-names>JF</given-names></name><name><surname>Smits</surname><given-names>SL</given-names></name><name><surname>El Tahir</surname><given-names>YE</given-names></name><name><surname>De Sousa</surname><given-names>R</given-names></name><name><surname>van Beek</surname><given-names>J</given-names></name><name><surname>Nowotny</surname><given-names>N</given-names></name><name><surname>van Maanen</surname><given-names>K</given-names></name><name><surname>Hidalgo-Hermoso</surname><given-names>E</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><name><surname>Rottier</surname><given-names>P</given-names></name><name><surname>Osterhaus</surname><given-names>A</given-names></name><name><surname>Gortazar-Schmidt</surname><given-names>C</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Koopmans</surname><given-names>MP</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study</article-title><source>Lancet Infect Dis</source><year>2013</year><volume>13</volume><fpage>859</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(13)70164-6</pub-id><?supplied-pmid 23933067?><pub-id pub-id-type="pmid">23933067</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azhar</surname><given-names>EI</given-names></name><name><surname>El-Kafrawy</surname><given-names>SA</given-names></name><name><surname>Farraj</surname><given-names>SA</given-names></name><name><surname>Hassan</surname><given-names>AM</given-names></name><name><surname>Al-Saeed</surname><given-names>MS</given-names></name><name><surname>Hashem</surname><given-names>AM</given-names></name><name><surname>Madani</surname><given-names>TA</given-names></name></person-group><article-title>Evidence for camel-to-human transmission of MERS coronavirus</article-title><source>N Engl J Med</source><year>2014</year><volume>370</volume><fpage>2499</fpage><lpage>2505</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1401505</pub-id><?supplied-pmid 24896817?><pub-id pub-id-type="pmid">24896817</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemida</surname><given-names>MG</given-names></name><name><surname>Chu</surname><given-names>DK</given-names></name><name><surname>Poon</surname><given-names>LL</given-names></name><name><surname>Perera</surname><given-names>RA</given-names></name><name><surname>Alhammadi</surname><given-names>MA</given-names></name><name><surname>Ng</surname><given-names>HY</given-names></name><name><surname>Siu</surname><given-names>LY</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Alnaeem</surname><given-names>A</given-names></name><name><surname>Peiris</surname><given-names>M</given-names></name></person-group><article-title>MERS coronavirus in dromedary camel herd, Saudi Arabia</article-title><source>Emerg Infect Dis</source><year>2014</year><volume>20</volume><fpage>1231</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.3201/eid2007.140571</pub-id><?supplied-pmid 24964193?><pub-id pub-id-type="pmid">24964193</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raj</surname><given-names>VS</given-names></name><name><surname>Farag</surname><given-names>EA</given-names></name><name><surname>Reusken</surname><given-names>CB</given-names></name><name><surname>Lamers</surname><given-names>MM</given-names></name><name><surname>Pas</surname><given-names>SD</given-names></name><name><surname>Voermans</surname><given-names>J</given-names></name><name><surname>Smits</surname><given-names>SL</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Al-Mawlawi</surname><given-names>N</given-names></name><name><surname>Al-Romaihi</surname><given-names>HE</given-names></name><name><surname>AlHajri</surname><given-names>MM</given-names></name><name><surname>El-Sayed</surname><given-names>AM</given-names></name><name><surname>Mohran</surname><given-names>KA</given-names></name><name><surname>Ghobashy</surname><given-names>H</given-names></name><name><surname>Alhajri</surname><given-names>F</given-names></name><name><surname>Al-Thani</surname><given-names>M</given-names></name><name><surname>Al-Marri</surname><given-names>SA</given-names></name><name><surname>El-Maghraby</surname><given-names>MM</given-names></name><name><surname>Koopmans</surname><given-names>MP</given-names></name><name><surname>Haagmans</surname><given-names>BL</given-names></name></person-group><article-title>Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014</article-title><source>Emerg Infect Dis</source><year>2014</year><volume>20</volume><fpage>1339</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.3201/eid2008.140663</pub-id><?supplied-pmid 25075761?><pub-id pub-id-type="pmid">25075761</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>XY</given-names></name><name><surname>Li</surname><given-names>JL</given-names></name><name><surname>Yang</surname><given-names>XL</given-names></name><name><surname>Chmura</surname><given-names>AA</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Epstein</surname><given-names>JH</given-names></name><name><surname>Mazet</surname><given-names>JK</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Luo</surname><given-names>CM</given-names></name><name><surname>Tan</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Crameri</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><name><surname>Wang</surname><given-names>LF</given-names></name><name><surname>Daszak</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>ZL</given-names></name></person-group><article-title>Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor</article-title><source>Nature</source><year>2013</year><volume>503</volume><fpage>535</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1038/nature12711</pub-id><?supplied-pmid 24172901?><pub-id pub-id-type="pmid">24172901</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Epstein</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Crameri</surname><given-names>G</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>McEachern</surname><given-names>J</given-names></name><name><surname>Field</surname><given-names>H</given-names></name><name><surname>Daszak</surname><given-names>P</given-names></name><name><surname>Eaton</surname><given-names>BT</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>LF</given-names></name></person-group><article-title>Bats are natural reservoirs of SARS-like coronaviruses</article-title><source>Science</source><year>2005</year><volume>310</volume><fpage>676</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1126/science.1118391</pub-id><?supplied-pmid 16195424?><pub-id pub-id-type="pmid">16195424</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rota</surname><given-names>PA</given-names></name><name><surname>Oberste</surname><given-names>MS</given-names></name><name><surname>Monroe</surname><given-names>SS</given-names></name><name><surname>Nix</surname><given-names>WA</given-names></name><name><surname>Campagnoli</surname><given-names>R</given-names></name><name><surname>Icenogle</surname><given-names>JP</given-names></name><name><surname>Penaranda</surname><given-names>S</given-names></name><name><surname>Bankamp</surname><given-names>B</given-names></name><name><surname>Maher</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>MH</given-names></name><name><surname>Tong</surname><given-names>S</given-names></name><name><surname>Tamin</surname><given-names>A</given-names></name><name><surname>Lowe</surname><given-names>L</given-names></name><name><surname>Frace</surname><given-names>M</given-names></name><name><surname>DeRisi</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Erdman</surname><given-names>DD</given-names></name><name><surname>Peret</surname><given-names>TC</given-names></name><name><surname>Burns</surname><given-names>C</given-names></name><name><surname>Ksiazek</surname><given-names>TG</given-names></name><name><surname>Rollin</surname><given-names>PE</given-names></name><name><surname>Sanchez</surname><given-names>A</given-names></name><name><surname>Liffick</surname><given-names>S</given-names></name><name><surname>Holloway</surname><given-names>B</given-names></name><name><surname>Limor</surname><given-names>J</given-names></name><name><surname>McCaustland</surname><given-names>K</given-names></name><name><surname>Olsen-Rasmussen</surname><given-names>M</given-names></name><name><surname>Fouchier</surname><given-names>R</given-names></name><name><surname>Gunther</surname><given-names>S</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Pallansch</surname><given-names>MA</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Bellini</surname><given-names>WJ</given-names></name></person-group><article-title>Characterization of a novel coronavirus associated with severe acute respiratory syndrome</article-title><source>Science</source><year>2003</year><volume>300</volume><fpage>1394</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1126/science.1085952</pub-id><?supplied-pmid 12730500?><pub-id pub-id-type="pmid">12730500</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alshukairi</surname><given-names>AN</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Nehdi</surname><given-names>A</given-names></name><name><surname>Baharoon</surname><given-names>SA</given-names></name><name><surname>Layqah</surname><given-names>L</given-names></name><name><surname>Bokhari</surname><given-names>A</given-names></name><name><surname>Al Johani</surname><given-names>SM</given-names></name><name><surname>Samman</surname><given-names>N</given-names></name><name><surname>Boudjelal</surname><given-names>M</given-names></name><name><surname>Ten Eyck</surname><given-names>P</given-names></name><name><surname>Al-Mozaini</surname><given-names>MA</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Perlman</surname><given-names>S</given-names></name><name><surname>Alagaili</surname><given-names>AN</given-names></name></person-group><article-title>High prevalence of MERS-CoV infection in camel workers in Saudi Arabia</article-title><source>MBio</source><year>2018</year><volume>9</volume><fpage>e01985-18</fpage><pub-id pub-id-type="doi">10.1128/mBio.01985-18</pub-id><?supplied-pmid 30377284?><pub-id pub-id-type="pmid">30377284</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skowronski</surname><given-names>DM</given-names></name><name><surname>Astell</surname><given-names>C</given-names></name><name><surname>Brunham</surname><given-names>RC</given-names></name><name><surname>Low</surname><given-names>DE</given-names></name><name><surname>Petric</surname><given-names>M</given-names></name><name><surname>Roper</surname><given-names>RL</given-names></name><name><surname>Talbot</surname><given-names>PJ</given-names></name><name><surname>Tam</surname><given-names>T</given-names></name><name><surname>Babiuk</surname><given-names>L</given-names></name></person-group><article-title>Severe acute respiratory syndrome (SARS): a year in review</article-title><source>Annu Rev Med</source><year>2005</year><volume>56</volume><fpage>357</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1146/annurev.med.56.091103.134135</pub-id><?supplied-pmid 15660517?><pub-id pub-id-type="pmid">15660517</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/mers-cov/en/">https://www.who.int/emergencies/mers-cov/en/</ext-link>. Accessed 10 Apr 2019.</mixed-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>SY</given-names></name><name><surname>Kang</surname><given-names>JM</given-names></name><name><surname>Ha</surname><given-names>YE</given-names></name><name><surname>Park</surname><given-names>GE</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Ko</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Kang</surname><given-names>CI</given-names></name><name><surname>Jo</surname><given-names>IJ</given-names></name><name><surname>Ryu</surname><given-names>JG</given-names></name><name><surname>Choi</surname><given-names>JR</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Huh</surname><given-names>HJ</given-names></name><name><surname>Ki</surname><given-names>CS</given-names></name><name><surname>Kang</surname><given-names>ES</given-names></name><name><surname>Peck</surname><given-names>KR</given-names></name><name><surname>Dhong</surname><given-names>HJ</given-names></name><name><surname>Song</surname><given-names>JH</given-names></name><name><surname>Chung</surname><given-names>DR</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name></person-group><article-title>MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study</article-title><source>Lancet</source><year>2016</year><volume>388</volume><fpage>994</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)30623-7</pub-id><?supplied-pmid 27402381?><pub-id pub-id-type="pmid">27402381</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowell</surname><given-names>G</given-names></name><name><surname>Abdirizak</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Jung</surname><given-names>E</given-names></name><name><surname>Nishiura</surname><given-names>H</given-names></name><name><surname>Viboud</surname><given-names>C</given-names></name></person-group><article-title>Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study</article-title><source>BMC Med</source><year>2015</year><volume>13</volume><fpage>210</fpage><pub-id pub-id-type="doi">10.1186/s12916-015-0450-0</pub-id><?supplied-pmid 26336062?><pub-id pub-id-type="pmid">26336062</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>JC</given-names></name><name><surname>Nguyen</surname><given-names>D</given-names></name><name><surname>Aden</surname><given-names>B</given-names></name><name><surname>Al Bandar</surname><given-names>Z</given-names></name><name><surname>Al Dhaheri</surname><given-names>W</given-names></name><name><surname>Abu Elkheir</surname><given-names>K</given-names></name><name><surname>Khudair</surname><given-names>A</given-names></name><name><surname>Al Mulla</surname><given-names>M</given-names></name><name><surname>El Saleh</surname><given-names>F</given-names></name><name><surname>Imambaccus</surname><given-names>H</given-names></name><name><surname>Al Kaabi</surname><given-names>N</given-names></name><name><surname>Sheikh</surname><given-names>FA</given-names></name><name><surname>Sasse</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>A</given-names></name><name><surname>Abdel Wareth</surname><given-names>L</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Al Ameri</surname><given-names>A</given-names></name><name><surname>Abu Amer</surname><given-names>W</given-names></name><name><surname>Alami</surname><given-names>NN</given-names></name><name><surname>Bunga</surname><given-names>S</given-names></name><name><surname>Haynes</surname><given-names>LM</given-names></name><name><surname>Hall</surname><given-names>AJ</given-names></name><name><surname>Kallen</surname><given-names>AJ</given-names></name><name><surname>Kuhar</surname><given-names>D</given-names></name><name><surname>Pham</surname><given-names>H</given-names></name><name><surname>Pringle</surname><given-names>K</given-names></name><name><surname>Tong</surname><given-names>S</given-names></name><name><surname>Whitaker</surname><given-names>BL</given-names></name><name><surname>Gerber</surname><given-names>SI</given-names></name><name><surname>Al Hosani</surname><given-names>FI</given-names></name></person-group><article-title>Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi</article-title><source>Emerg Infect Dis</source><year>2016</year><volume>22</volume><fpage>647</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.3201/eid2204.151615</pub-id><?supplied-pmid 26981708?><pub-id pub-id-type="pmid">26981708</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Carroll</surname><given-names>DS</given-names></name><name><surname>Gardner</surname><given-names>SN</given-names></name><name><surname>Walsh</surname><given-names>MC</given-names></name><name><surname>Vitalis</surname><given-names>EA</given-names></name><name><surname>Damon</surname><given-names>IK</given-names></name></person-group><article-title>On the origin of smallpox: correlating variola phylogenics with historical smallpox records</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>15787</fpage><lpage>15792</lpage><pub-id pub-id-type="doi">10.1073/pnas.0609268104</pub-id><?supplied-pmid 17901212?><pub-id pub-id-type="pmid">17901212</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fenner</surname><given-names>FHD</given-names></name><name><surname>Isao</surname><given-names>A</given-names></name><name><surname>Zdenek</surname><given-names>J</given-names></name><name><surname>Ladnyi</surname><given-names>ID</given-names></name></person-group><source>Smallpox and its eradication</source><year>1988</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Koplow</surname><given-names>DA</given-names></name></person-group><source>Smallpox: the fight to eradicate a global scourge</source><year>2004</year><publisher-loc>Berkeley</publisher-loc><publisher-name>University of California Press</publisher-name></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riedel</surname><given-names>S</given-names></name></person-group><article-title>Edward Jenner and the history of smallpox and vaccination</article-title><source>Proc (Bayl Univ Med Cent)</source><year>2005</year><volume>18</volume><fpage>21</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1080/08998280.2005.11928028</pub-id><pub-id pub-id-type="pmid">16200144</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Killingley</surname><given-names>B</given-names></name><name><surname>Nguyen-Van-Tam</surname><given-names>J</given-names></name></person-group><article-title>Routes of influenza transmission</article-title><source>Influenza Other Respir Viruses</source><year>2013</year><volume>7</volume><issue>Suppl 2</issue><fpage>42</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1111/irv.12080</pub-id><?supplied-pmid 24034483?><pub-id pub-id-type="pmid">24034483</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridges</surname><given-names>CB</given-names></name><name><surname>Kuehnert</surname><given-names>MJ</given-names></name><name><surname>Hall</surname><given-names>CB</given-names></name></person-group><article-title>Transmission of influenza: implications for control in health care settings</article-title><source>Clin Infect Dis</source><year>2003</year><volume>37</volume><fpage>1094</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.1086/378292</pub-id><?supplied-pmid 14523774?><pub-id pub-id-type="pmid">14523774</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Riel</surname><given-names>D</given-names></name><name><surname>Munster</surname><given-names>VJ</given-names></name><name><surname>de Wit</surname><given-names>E</given-names></name><name><surname>Rimmelzwaan</surname><given-names>GF</given-names></name><name><surname>Fouchier</surname><given-names>RA</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Kuiken</surname><given-names>T</given-names></name></person-group><article-title>Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals</article-title><source>Am J Pathol</source><year>2007</year><volume>171</volume><fpage>1215</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.070248</pub-id><?supplied-pmid 17717141?><pub-id pub-id-type="pmid">17717141</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinya</surname><given-names>K</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group><article-title>Influenza virus receptors in the human airway</article-title><source>Uirusu</source><year>2006</year><volume>56</volume><fpage>85</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.2222/jsv.56.85</pub-id><?supplied-pmid 17038816?><pub-id pub-id-type="pmid">17038816</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baccam</surname><given-names>P</given-names></name><name><surname>Beauchemin</surname><given-names>C</given-names></name><name><surname>Macken</surname><given-names>CA</given-names></name><name><surname>Hayden</surname><given-names>FG</given-names></name><name><surname>Perelson</surname><given-names>AS</given-names></name></person-group><article-title>Kinetics of influenza A virus infection in humans</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>7590</fpage><lpage>7599</lpage><pub-id pub-id-type="doi">10.1128/JVI.01623-05</pub-id><?supplied-pmid 16840338?><pub-id pub-id-type="pmid">16840338</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>S</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Kuan</surname><given-names>G</given-names></name><name><surname>Gresh</surname><given-names>L</given-names></name><name><surname>Balmaseda</surname><given-names>A</given-names></name><name><surname>Harris</surname><given-names>E</given-names></name><name><surname>Gordon</surname><given-names>A</given-names></name></person-group><article-title>The timeline of influenza virus shedding in children and adults in a household transmission study of influenza in Managua, Nicaragua</article-title><source>Pediatr Infect Dis J</source><year>2016</year><volume>35</volume><fpage>583</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1097/INF.0000000000001083</pub-id><?supplied-pmid 26910589?><pub-id pub-id-type="pmid">26910589</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehners</surname><given-names>N</given-names></name><name><surname>Tabatabai</surname><given-names>J</given-names></name><name><surname>Prifert</surname><given-names>C</given-names></name><name><surname>Wedde</surname><given-names>M</given-names></name><name><surname>Puthenparambil</surname><given-names>J</given-names></name><name><surname>Weissbrich</surname><given-names>B</given-names></name><name><surname>Biere</surname><given-names>B</given-names></name><name><surname>Schweiger</surname><given-names>B</given-names></name><name><surname>Egerer</surname><given-names>G</given-names></name><name><surname>Schnitzler</surname><given-names>P</given-names></name></person-group><article-title>Long-term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><fpage>e0148258</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0148258</pub-id><?supplied-pmid 26866481?><pub-id pub-id-type="pmid">26866481</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biggerstaff</surname><given-names>M</given-names></name><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Reed</surname><given-names>C</given-names></name><name><surname>Gambhir</surname><given-names>M</given-names></name><name><surname>Finelli</surname><given-names>L</given-names></name></person-group><article-title>Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature</article-title><source>BMC Infect Dis</source><year>2014</year><volume>14</volume><fpage>480</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-14-480</pub-id><?supplied-pmid 25186370?><pub-id pub-id-type="pmid">25186370</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herold</surname><given-names>S</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>Ridge</surname><given-names>KM</given-names></name><name><surname>Budinger</surname><given-names>GR</given-names></name></person-group><article-title>Influenza virus-induced lung injury: pathogenesis and implications for treatment</article-title><source>Eur Respir J</source><year>2015</year><volume>45</volume><fpage>1463</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1183/09031936.00186214</pub-id><?supplied-pmid 25792631?><pub-id pub-id-type="pmid">25792631</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>JK</given-names></name><name><surname>Morens</surname><given-names>DM</given-names></name></person-group><article-title>The pathology of influenza virus infections</article-title><source>Annu Rev Pathol</source><year>2008</year><volume>3</volume><fpage>499</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1146/annurev.pathmechdis.3.121806.154316</pub-id><?supplied-pmid 18039138?><pub-id pub-id-type="pmid">18039138</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chertow</surname><given-names>DS</given-names></name><name><surname>Memoli</surname><given-names>MJ</given-names></name></person-group><article-title>Bacterial coinfection in influenza: a grand rounds review</article-title><source>JAMA</source><year>2013</year><volume>309</volume><fpage>275</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1001/jama.2012.194139</pub-id><?supplied-pmid 23321766?><pub-id pub-id-type="pmid">23321766</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>C</given-names></name><name><surname>Mok</surname><given-names>CKP</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Chu</surname><given-names>DKW</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Zhong</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Peiris</surname><given-names>JSM</given-names></name></person-group><article-title>Human infection with highly pathogenic avian influenza A(H7N9) virus, China</article-title><source>Emerg Infect Dis</source><year>2017</year><volume>23</volume><fpage>1332</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.3201/eid2308.170600</pub-id><?supplied-pmid 28580899?><pub-id pub-id-type="pmid">28580899</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luczo</surname><given-names>JM</given-names></name><name><surname>Stambas</surname><given-names>J</given-names></name><name><surname>Durr</surname><given-names>PA</given-names></name><name><surname>Michalski</surname><given-names>WP</given-names></name><name><surname>Bingham</surname><given-names>J</given-names></name></person-group><article-title>Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif</article-title><source>Rev Med Virol</source><year>2015</year><volume>25</volume><fpage>406</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1002/rmv.1846</pub-id><?supplied-pmid 26467906?><pub-id pub-id-type="pmid">26467906</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez Lorenzo</surname><given-names>MM</given-names></name><name><surname>Fenton</surname><given-names>MJ</given-names></name></person-group><article-title>Immunobiology of influenza vaccines</article-title><source>Chest</source><year>2013</year><volume>143</volume><fpage>502</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1378/chest.12-1711</pub-id><?supplied-pmid 23381315?><pub-id pub-id-type="pmid">23381315</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remington</surname><given-names>PL</given-names></name><name><surname>Hall</surname><given-names>WN</given-names></name><name><surname>Davis</surname><given-names>IH</given-names></name><name><surname>Herald</surname><given-names>A</given-names></name><name><surname>Gunn</surname><given-names>RA</given-names></name></person-group><article-title>Airborne transmission of measles in a physician&#x02019;s office</article-title><source>JAMA</source><year>1985</year><volume>253</volume><fpage>1574</fpage><lpage>1577</lpage><pub-id pub-id-type="doi">10.1001/jama.1985.03350350068022</pub-id><?supplied-pmid 3974036?><pub-id pub-id-type="pmid">3974036</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laksono</surname><given-names>BM</given-names></name><name><surname>de Vries</surname><given-names>RD</given-names></name><name><surname>McQuaid</surname><given-names>S</given-names></name><name><surname>Duprex</surname><given-names>WP</given-names></name><name><surname>de Swart</surname><given-names>RL</given-names></name></person-group><article-title>Measles virus host invasion and pathogenesis</article-title><source>Viruses</source><year>2016</year><volume>8</volume><fpage>210</fpage><pub-id pub-id-type="doi">10.3390/v8080210</pub-id><?supplied-pmid 4997572?><pub-id pub-id-type="pmid">4997572</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludlow</surname><given-names>M</given-names></name><name><surname>McQuaid</surname><given-names>S</given-names></name><name><surname>Milner</surname><given-names>D</given-names></name><name><surname>de Swart</surname><given-names>RL</given-names></name><name><surname>Duprex</surname><given-names>WP</given-names></name></person-group><article-title>Pathological consequences of systemic measles virus infection</article-title><source>J Pathol</source><year>2015</year><volume>235</volume><fpage>253</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1002/path.4457</pub-id><?supplied-pmid 25294240?><pub-id pub-id-type="pmid">25294240</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Swart</surname><given-names>RL</given-names></name><name><surname>Ludlow</surname><given-names>M</given-names></name><name><surname>de Witte</surname><given-names>L</given-names></name><name><surname>Yanagi</surname><given-names>Y</given-names></name><name><surname>van Amerongen</surname><given-names>G</given-names></name><name><surname>McQuaid</surname><given-names>S</given-names></name><name><surname>Yuksel</surname><given-names>S</given-names></name><name><surname>Geijtenbeek</surname><given-names>TB</given-names></name><name><surname>Duprex</surname><given-names>WP</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name></person-group><article-title>Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques</article-title><source>PLoS Pathog</source><year>2007</year><volume>3</volume><fpage>e178</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.0030178</pub-id><?supplied-pmid 18020706?><pub-id pub-id-type="pmid">18020706</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>RT</given-names></name><name><surname>Halsey</surname><given-names>NA</given-names></name></person-group><article-title>The clinical significance of measles: a review</article-title><source>J Infect Dis</source><year>2004</year><volume>189</volume><issue>Suppl 1</issue><fpage>S4</fpage><lpage>16</lpage><?supplied-pmid 15106083?><pub-id pub-id-type="pmid">15106083</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerra</surname><given-names>FM</given-names></name><name><surname>Bolotin</surname><given-names>S</given-names></name><name><surname>Lim</surname><given-names>G</given-names></name><name><surname>Heffernan</surname><given-names>J</given-names></name><name><surname>Deeks</surname><given-names>SL</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Crowcroft</surname><given-names>NS</given-names></name></person-group><article-title>The basic reproduction number (R0) of measles: a systematic review</article-title><source>Lancet Infect Dis</source><year>2017</year><volume>17</volume><fpage>e420</fpage><lpage>e428</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(17)30307-9</pub-id><?supplied-pmid 28757186?><pub-id pub-id-type="pmid">28757186</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leuridan</surname><given-names>E</given-names></name><name><surname>Hens</surname><given-names>N</given-names></name><name><surname>Hutse</surname><given-names>V</given-names></name><name><surname>Ieven</surname><given-names>M</given-names></name><name><surname>Aerts</surname><given-names>M</given-names></name><name><surname>Van Damme</surname><given-names>P</given-names></name></person-group><article-title>Early waning of maternal measles antibodies in era of measles elimination: longitudinal study</article-title><source>BMJ</source><year>2010</year><volume>340</volume><fpage>c1626</fpage><pub-id pub-id-type="doi">10.1136/bmj.c1626</pub-id><?supplied-pmid 20483946?><pub-id pub-id-type="pmid">20483946</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>DE</given-names></name></person-group><article-title>Measles virus-induced suppression of immune responses</article-title><source>Immunol Rev</source><year>2010</year><volume>236</volume><fpage>176</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2010.00925.x</pub-id><?supplied-pmid 20636817?><pub-id pub-id-type="pmid">20636817</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mina</surname><given-names>MJ</given-names></name><name><surname>Metcalf</surname><given-names>CJ</given-names></name><name><surname>de Swart</surname><given-names>RL</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality</article-title><source>Science</source><year>2015</year><volume>348</volume><fpage>694</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1126/science.aaa3662</pub-id><?supplied-pmid 25954009?><pub-id pub-id-type="pmid">25954009</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>IT</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wong</surname><given-names>TW</given-names></name><name><surname>Tam</surname><given-names>W</given-names></name><name><surname>Chan</surname><given-names>AT</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Leung</surname><given-names>DY</given-names></name><name><surname>Ho</surname><given-names>T</given-names></name></person-group><article-title>Evidence of airborne transmission of the severe acute respiratory syndrome virus</article-title><source>N Engl J Med</source><year>2004</year><volume>350</volume><fpage>1731</fpage><lpage>1739</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa032867</pub-id><?supplied-pmid 15102999?><pub-id pub-id-type="pmid">15102999</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowell</surname><given-names>G</given-names></name><name><surname>Castillo-Chavez</surname><given-names>C</given-names></name><name><surname>Fenimore</surname><given-names>PW</given-names></name><name><surname>Kribs-Zaleta</surname><given-names>CM</given-names></name><name><surname>Arriola</surname><given-names>L</given-names></name><name><surname>Hyman</surname><given-names>JM</given-names></name></person-group><article-title>Model parameters and outbreak control for SARS</article-title><source>Emerg Infect Dis</source><year>2004</year><volume>10</volume><fpage>1258</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.3201/eid1007.030647</pub-id><?supplied-pmid 15324546?><pub-id pub-id-type="pmid">15324546</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name><name><surname>Alvarez</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Lam</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Lackner</surname><given-names>A</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name></person-group><article-title>Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques</article-title><source>J Virol</source><year>2011</year><volume>85</volume><fpage>4025</fpage><lpage>4030</lpage><pub-id pub-id-type="doi">10.1128/JVI.02292-10</pub-id><?supplied-pmid 21289121?><pub-id pub-id-type="pmid">21289121</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuba</surname><given-names>K</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>Guan</surname><given-names>B</given-names></name><name><surname>Huan</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>W</given-names></name><name><surname>Bao</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Chappell</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Leibbrandt</surname><given-names>A</given-names></name><name><surname>Wada</surname><given-names>T</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name></person-group><article-title>A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury</article-title><source>Nat Med</source><year>2005</year><volume>11</volume><fpage>875</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1038/nm1267</pub-id><?supplied-pmid 16007097?><pub-id pub-id-type="pmid">16007097</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>W</given-names></name><name><surname>Zhan</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Zhuang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Shao</surname><given-names>H</given-names></name><name><surname>Fang</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Pei</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Anderson</surname><given-names>VM</given-names></name><name><surname>Leong</surname><given-names>AS</given-names></name></person-group><article-title>Multiple organ infection and the pathogenesis of SARS</article-title><source>J Exp Med</source><year>2005</year><volume>202</volume><fpage>415</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1084/jem.20050828</pub-id><?supplied-pmid 16043521?><pub-id pub-id-type="pmid">16043521</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamming</surname><given-names>I</given-names></name><name><surname>Timens</surname><given-names>W</given-names></name><name><surname>Bulthuis</surname><given-names>ML</given-names></name><name><surname>Lely</surname><given-names>AT</given-names></name><name><surname>Navis</surname><given-names>G</given-names></name><name><surname>van Goor</surname><given-names>H</given-names></name></person-group><article-title>Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis</article-title><source>J Pathol</source><year>2004</year><volume>203</volume><fpage>631</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1002/path.1570</pub-id><?supplied-pmid 15141377?><pub-id pub-id-type="pmid">15141377</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Korteweg</surname><given-names>C</given-names></name></person-group><article-title>Pathology and pathogenesis of severe acute respiratory syndrome</article-title><source>Am J Pathol</source><year>2007</year><volume>170</volume><fpage>1136</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.061088</pub-id><?supplied-pmid 17392154?><pub-id pub-id-type="pmid">17392154</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="other">Middle East Respiratory Syndrome Coronavirus (MERS-CoV). WHO MERS-CoV Global Summary and risk assessment. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/mers-cov/mers-summary-2016.pdf">https://www.who.int/emergencies/mers-cov/mers-summary-2016.pdf</ext-link>. Accessed 19 Apr 2017.</mixed-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corman</surname><given-names>VM</given-names></name><name><surname>Albarrak</surname><given-names>AM</given-names></name><name><surname>Omrani</surname><given-names>AS</given-names></name><name><surname>Albarrak</surname><given-names>MM</given-names></name><name><surname>Farah</surname><given-names>ME</given-names></name><name><surname>Almasri</surname><given-names>M</given-names></name><name><surname>Muth</surname><given-names>D</given-names></name><name><surname>Sieberg</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>B</given-names></name><name><surname>Assiri</surname><given-names>AM</given-names></name><name><surname>Binger</surname><given-names>T</given-names></name><name><surname>Steinhagen</surname><given-names>K</given-names></name><name><surname>Lattwein</surname><given-names>E</given-names></name><name><surname>Al-Tawfiq</surname><given-names>J</given-names></name><name><surname>Muller</surname><given-names>MA</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name></person-group><article-title>Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection</article-title><source>Clin Infect Dis</source><year>2016</year><volume>62</volume><fpage>477</fpage><lpage>483</lpage><?supplied-pmid 26565003?><pub-id pub-id-type="pmid">26565003</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>MD</given-names></name><name><surname>Park</surname><given-names>WB</given-names></name><name><surname>Choe</surname><given-names>PG</given-names></name><name><surname>Choi</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>JI</given-names></name><name><surname>Chae</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>SS</given-names></name><name><surname>Kim</surname><given-names>EC</given-names></name><name><surname>Oh</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>EJ</given-names></name><name><surname>Nam</surname><given-names>EY</given-names></name><name><surname>Na</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Song</surname><given-names>KH</given-names></name><name><surname>Bang</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>ES</given-names></name><name><surname>Kim</surname><given-names>HB</given-names></name><name><surname>Park</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>NJ</given-names></name></person-group><article-title>Viral load kinetics of MERS coronavirus infection</article-title><source>N Engl J Med</source><year>2016</year><volume>375</volume><fpage>1303</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1511695</pub-id><?supplied-pmid 27682053?><pub-id pub-id-type="pmid">27682053</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Bao</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>P</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name></person-group><article-title>From SARS to MERS, thrusting coronaviruses into the spotlight</article-title><source>Viruses</source><year>2019</year><volume>11</volume><fpage>59</fpage><pub-id pub-id-type="doi">10.3390/v11010059</pub-id><?supplied-pmid 6357155?><pub-id pub-id-type="pmid">6357155</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Cho</surname><given-names>SY</given-names></name><name><surname>Cha</surname><given-names>RH</given-names></name><name><surname>Jee</surname><given-names>HG</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Shin</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Jung</surname><given-names>YM</given-names></name><name><surname>Yang</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Cho</surname><given-names>SI</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Seo</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>SS</given-names></name><name><surname>Seong</surname><given-names>MW</given-names></name></person-group><article-title>Viral RNA in blood as indicator of severe outcome in Middle East respiratory syndrome coronavirus infection</article-title><source>Emerg Infect Dis</source><year>2016</year><volume>22</volume><fpage>1813</fpage><lpage>1816</lpage><pub-id pub-id-type="doi">10.3201/eid2210.160218</pub-id><?supplied-pmid 27479636?><pub-id pub-id-type="pmid">27479636</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widagdo</surname><given-names>W</given-names></name><name><surname>Raj</surname><given-names>VS</given-names></name><name><surname>Schipper</surname><given-names>D</given-names></name><name><surname>Kolijn</surname><given-names>K</given-names></name><name><surname>van Leenders</surname><given-names>G</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><name><surname>Bensaid</surname><given-names>A</given-names></name><name><surname>Segales</surname><given-names>J</given-names></name><name><surname>Baumgartner</surname><given-names>W</given-names></name><name><surname>Osterhaus</surname><given-names>A</given-names></name><name><surname>Koopmans</surname><given-names>MP</given-names></name><name><surname>van den Brand</surname><given-names>JMA</given-names></name><name><surname>Haagmans</surname><given-names>BL</given-names></name></person-group><article-title>Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels</article-title><source>J Virol</source><year>2016</year><volume>90</volume><fpage>4838</fpage><lpage>4842</lpage><pub-id pub-id-type="doi">10.1128/JVI.02994-15</pub-id><?supplied-pmid 26889022?><pub-id pub-id-type="pmid">26889022</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehrle</surname><given-names>PF</given-names></name><name><surname>Posch</surname><given-names>J</given-names></name><name><surname>Richter</surname><given-names>KH</given-names></name><name><surname>Henderson</surname><given-names>DA</given-names></name></person-group><article-title>An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe</article-title><source>Bull World Health Organ</source><year>1970</year><volume>43</volume><fpage>669</fpage><lpage>679</lpage><?supplied-pmid 5313258?><pub-id pub-id-type="pmid">5313258</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichner</surname><given-names>M</given-names></name><name><surname>Dietz</surname><given-names>K</given-names></name></person-group><article-title>Transmission potential of smallpox: estimates based on detailed data from an outbreak</article-title><source>Am J Epidemiol</source><year>2003</year><volume>158</volume><fpage>110</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1093/aje/kwg103</pub-id><?supplied-pmid 12851223?><pub-id pub-id-type="pmid">12851223</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breman</surname><given-names>JG</given-names></name><name><surname>Henderson</surname><given-names>DA</given-names></name></person-group><article-title>Diagnosis and management of smallpox</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><fpage>1300</fpage><lpage>1308</lpage><pub-id pub-id-type="doi">10.1056/NEJMra020025</pub-id><?supplied-pmid 11923491?><pub-id pub-id-type="pmid">11923491</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanford</surname><given-names>MM</given-names></name><name><surname>McFadden</surname><given-names>G</given-names></name><name><surname>Karupiah</surname><given-names>G</given-names></name><name><surname>Chaudhri</surname><given-names>G</given-names></name></person-group><article-title>Immunopathogenesis of poxvirus infections: forecasting the impending storm</article-title><source>Immunol Cell Biol</source><year>2007</year><volume>85</volume><fpage>93</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1038/sj.icb.7100033</pub-id><?supplied-pmid 17228320?><pub-id pub-id-type="pmid">17228320</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>DB</given-names></name></person-group><article-title>The cause of death in smallpox: an examination of the pathology record</article-title><source>Mil Med</source><year>2002</year><volume>167</volume><fpage>546</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1093/milmed/167.7.546</pub-id><?supplied-pmid 12125845?><pub-id pub-id-type="pmid">12125845</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>JK</given-names></name><name><surname>Mitra</surname><given-names>AC</given-names></name><name><surname>Mukherjee</surname><given-names>MK</given-names></name><name><surname>De</surname><given-names>SK</given-names></name><name><surname>Mazumdar</surname><given-names>DG</given-names></name></person-group><article-title>Virus excretion in smallpox. 1. Excretion in the throat, urine, and conjunctiva of patients</article-title><source>Bull World Health Organ</source><year>1973</year><volume>48</volume><fpage>517</fpage><lpage>522</lpage><?supplied-pmid 4359678?><pub-id pub-id-type="pmid">4359678</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guerrant</surname><given-names>RL</given-names></name><name><surname>Walker</surname><given-names>DH</given-names></name><name><surname>Weller</surname><given-names>PF</given-names></name></person-group><source>Tropical infectious diseases: principles, pathogens and practice</source><year>2011</year><publisher-loc>Saunders/Elsevier</publisher-loc><publisher-name>Edinburgh</publisher-name></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gani</surname><given-names>R</given-names></name><name><surname>Leach</surname><given-names>S</given-names></name></person-group><article-title>Transmission potential of smallpox in contemporary populations</article-title><source>Nature</source><year>2001</year><volume>414</volume><fpage>748</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1038/414748a</pub-id><?supplied-pmid 11742399?><pub-id pub-id-type="pmid">11742399</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downie</surname><given-names>AW</given-names></name><name><surname>Mc</surname><given-names>CK</given-names></name><name><surname>Macdonald</surname><given-names>A</given-names></name></person-group><article-title>Viraemia in smallpox</article-title><source>Lancet</source><year>1950</year><volume>2</volume><fpage>513</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(50)91496-6</pub-id><?supplied-pmid 14785197?><pub-id pub-id-type="pmid">14785197</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downie</surname><given-names>AW</given-names></name><name><surname>McCarthy</surname><given-names>K</given-names></name><name><surname>Macdonald</surname><given-names>A</given-names></name><name><surname>Maccallum</surname><given-names>FO</given-names></name><name><surname>Macrae</surname><given-names>AE</given-names></name></person-group><article-title>Virus and virus antigen in the blood of smallpox patients; their significance in early diagnosis and prognosis</article-title><source>Lancet</source><year>1953</year><volume>265</volume><fpage>164</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(53)90107-X</pub-id><?supplied-pmid 13070577?><pub-id pub-id-type="pmid">13070577</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>AC</given-names></name><name><surname>Chatterjee</surname><given-names>SN</given-names></name><name><surname>Sarkar</surname><given-names>JK</given-names></name><name><surname>Manji</surname><given-names>P</given-names></name><name><surname>Das</surname><given-names>AK</given-names></name></person-group><article-title>Viraemia in haemorrhagic and other forms of smallpox</article-title><source>J Indian Med Assoc</source><year>1966</year><volume>47</volume><fpage>112</fpage><lpage>114</lpage><?supplied-pmid 4288107?><pub-id pub-id-type="pmid">4288107</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>ZS</given-names></name><name><surname>Seward</surname><given-names>JF</given-names></name><name><surname>Lane</surname><given-names>JM</given-names></name></person-group><article-title>Smallpox</article-title><source>Lancet</source><year>2006</year><volume>367</volume><fpage>425</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)68143-9</pub-id><?supplied-pmid 16458769?><pub-id pub-id-type="pmid">16458769</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchman</surname><given-names>CA</given-names></name><name><surname>Doyle</surname><given-names>WJ</given-names></name><name><surname>Skoner</surname><given-names>DP</given-names></name><name><surname>Post</surname><given-names>JC</given-names></name><name><surname>Alper</surname><given-names>CM</given-names></name><name><surname>Seroky</surname><given-names>JT</given-names></name><name><surname>Anderson</surname><given-names>K</given-names></name><name><surname>Preston</surname><given-names>RA</given-names></name><name><surname>Hayden</surname><given-names>FG</given-names></name><name><surname>Fireman</surname><given-names>P</given-names></name><etal/></person-group><article-title>Influenza A virus--induced acute otitis media</article-title><source>J Infect Dis</source><year>1995</year><volume>172</volume><fpage>1348</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1093/infdis/172.5.1348</pub-id><?supplied-pmid 7594675?><pub-id pub-id-type="pmid">7594675</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellers</surname><given-names>SA</given-names></name><name><surname>Hagan</surname><given-names>RS</given-names></name><name><surname>Hayden</surname><given-names>FG</given-names></name><name><surname>Fischer</surname><given-names>WA</given-names><suffix>2nd</suffix></name></person-group><article-title>The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection</article-title><source>Influenza Other Respir Viruses</source><year>2017</year><volume>11</volume><fpage>372</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1111/irv.12470</pub-id><?supplied-pmid 28745014?><pub-id pub-id-type="pmid">28745014</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quiambao</surname><given-names>BP</given-names></name><name><surname>Gatchalian</surname><given-names>SR</given-names></name><name><surname>Halonen</surname><given-names>P</given-names></name><name><surname>Lucero</surname><given-names>M</given-names></name><name><surname>Sombrero</surname><given-names>L</given-names></name><name><surname>Paladin</surname><given-names>FJ</given-names></name><name><surname>Meurman</surname><given-names>O</given-names></name><name><surname>Merin</surname><given-names>J</given-names></name><name><surname>Ruutu</surname><given-names>P</given-names></name></person-group><article-title>Coinfection is common in measles-associated pneumonia</article-title><source>Pediatr Infect Dis J</source><year>1998</year><volume>17</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1097/00006454-199802000-00002</pub-id><?supplied-pmid 9493801?><pub-id pub-id-type="pmid">9493801</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>DE</given-names></name></person-group><article-title>Measles virus and the nervous system</article-title><source>Handb Clin Neurol</source><year>2014</year><volume>123</volume><fpage>577</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1016/B978-0-444-53488-0.00027-4</pub-id><?supplied-pmid 25015505?><pub-id pub-id-type="pmid">25015505</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>JS</given-names></name><name><surname>Lai</surname><given-names>ST</given-names></name><name><surname>Poon</surname><given-names>LL</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Yam</surname><given-names>LY</given-names></name><name><surname>Lim</surname><given-names>W</given-names></name><name><surname>Nicholls</surname><given-names>J</given-names></name><name><surname>Yee</surname><given-names>WK</given-names></name><name><surname>Yan</surname><given-names>WW</given-names></name><name><surname>Cheung</surname><given-names>MT</given-names></name><name><surname>Cheng</surname><given-names>VC</given-names></name><name><surname>Chan</surname><given-names>KH</given-names></name><name><surname>Tsang</surname><given-names>DN</given-names></name><name><surname>Yung</surname><given-names>RW</given-names></name><name><surname>Ng</surname><given-names>TK</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name><collab>SARS Study Group</collab></person-group><article-title>Coronavirus as a possible cause of severe acute respiratory syndrome</article-title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>1319</fpage><lpage>1325</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(03)13077-2</pub-id><pub-id pub-id-type="pmid">12711465</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>WK</given-names></name><name><surname>To</surname><given-names>KF</given-names></name><name><surname>Chan</surname><given-names>PK</given-names></name><name><surname>Chan</surname><given-names>HL</given-names></name><name><surname>Wu</surname><given-names>AK</given-names></name><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name></person-group><article-title>Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection</article-title><source>Gastroenterology</source><year>2003</year><volume>125</volume><fpage>1011</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.1016/j.gastro.2003.08.001</pub-id><?supplied-pmid 14517783?><pub-id pub-id-type="pmid">14517783</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Hedley</surname><given-names>AJ</given-names></name><name><surname>Ho</surname><given-names>LM</given-names></name><name><surname>Chau</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>IO</given-names></name><name><surname>Thach</surname><given-names>TQ</given-names></name><name><surname>Ghani</surname><given-names>AC</given-names></name><name><surname>Donnelly</surname><given-names>CA</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Anderson</surname><given-names>RM</given-names></name><name><surname>Tsang</surname><given-names>T</given-names></name><name><surname>Leung</surname><given-names>PY</given-names></name><name><surname>Wong</surname><given-names>V</given-names></name><name><surname>Chan</surname><given-names>JC</given-names></name><name><surname>Tsui</surname><given-names>E</given-names></name><name><surname>Lo</surname><given-names>SV</given-names></name><name><surname>Lam</surname><given-names>TH</given-names></name></person-group><article-title>The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients</article-title><source>Ann Intern Med</source><year>2004</year><volume>141</volume><fpage>662</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-141-9-200411020-00006</pub-id><?supplied-pmid 15520422?><pub-id pub-id-type="pmid">15520422</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>DS</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Zumla</surname><given-names>A</given-names></name></person-group><article-title>Severe acute respiratory syndrome vs. the Middle East respiratory syndrome</article-title><source>Curr Opin Pulm Med</source><year>2014</year><volume>20</volume><fpage>233</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1097/MCP.0000000000000046</pub-id><?supplied-pmid 24626235?><pub-id pub-id-type="pmid">24626235</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>DS</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name></person-group><article-title>Severe acute respiratory syndrome</article-title><source>Chest</source><year>2003</year><volume>124</volume><fpage>12</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1378/chest.124.1.12</pub-id><?supplied-pmid 12853495?><pub-id pub-id-type="pmid">12853495</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Hui</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Chan</surname><given-names>P</given-names></name><name><surname>Cameron</surname><given-names>P</given-names></name><name><surname>Joynt</surname><given-names>GM</given-names></name><name><surname>Ahuja</surname><given-names>A</given-names></name><name><surname>Yung</surname><given-names>MY</given-names></name><name><surname>Leung</surname><given-names>CB</given-names></name><name><surname>To</surname><given-names>KF</given-names></name><name><surname>Lui</surname><given-names>SF</given-names></name><name><surname>Szeto</surname><given-names>CC</given-names></name><name><surname>Chung</surname><given-names>S</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name></person-group><article-title>A major outbreak of severe acute respiratory syndrome in Hong Kong</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>1986</fpage><lpage>1994</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa030685</pub-id><?supplied-pmid 12682352?><pub-id pub-id-type="pmid">12682352</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>GW</given-names></name><name><surname>Hui</surname><given-names>DS</given-names></name></person-group><article-title>Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management</article-title><source>Thorax</source><year>2003</year><volume>58</volume><fpage>558</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1136/thorax.58.7.558</pub-id><?supplied-pmid 12832664?><pub-id pub-id-type="pmid">12832664</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>KH</given-names></name><name><surname>Tsang</surname><given-names>WK</given-names></name><name><surname>Tang</surname><given-names>CS</given-names></name><name><surname>Lam</surname><given-names>MF</given-names></name><name><surname>Lai</surname><given-names>FM</given-names></name><name><surname>To</surname><given-names>KF</given-names></name><name><surname>Fung</surname><given-names>KS</given-names></name><name><surname>Tang</surname><given-names>HL</given-names></name><name><surname>Yan</surname><given-names>WW</given-names></name><name><surname>Chan</surname><given-names>HW</given-names></name><name><surname>Lai</surname><given-names>TS</given-names></name><name><surname>Tong</surname><given-names>KL</given-names></name><name><surname>Lai</surname><given-names>KN</given-names></name></person-group><article-title>Acute renal impairment in coronavirus-associated severe acute respiratory syndrome</article-title><source>Kidney Int</source><year>2005</year><volume>67</volume><fpage>698</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1755.2005.67130.x</pub-id><?supplied-pmid 15673319?><pub-id pub-id-type="pmid">15673319</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assiri</surname><given-names>A</given-names></name><name><surname>Al-Tawfiq</surname><given-names>JA</given-names></name><name><surname>Al-Rabeeah</surname><given-names>AA</given-names></name><name><surname>Al-Rabiah</surname><given-names>FA</given-names></name><name><surname>Al-Hajjar</surname><given-names>S</given-names></name><name><surname>Al-Barrak</surname><given-names>A</given-names></name><name><surname>Flemban</surname><given-names>H</given-names></name><name><surname>Al-Nassir</surname><given-names>WN</given-names></name><name><surname>Balkhy</surname><given-names>HH</given-names></name><name><surname>Al-Hakeem</surname><given-names>RF</given-names></name><name><surname>Makhdoom</surname><given-names>HQ</given-names></name><name><surname>Zumla</surname><given-names>AI</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name></person-group><article-title>Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study</article-title><source>Lancet Infect Dis</source><year>2013</year><volume>13</volume><fpage>752</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(13)70204-4</pub-id><?supplied-pmid 23891402?><pub-id pub-id-type="pmid">23891402</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guery</surname><given-names>B</given-names></name><name><surname>Poissy</surname><given-names>J</given-names></name><name><surname>el Mansouf</surname><given-names>L</given-names></name><name><surname>Sejourne</surname><given-names>C</given-names></name><name><surname>Ettahar</surname><given-names>N</given-names></name><name><surname>Lemaire</surname><given-names>X</given-names></name><name><surname>Vuotto</surname><given-names>F</given-names></name><name><surname>Goffard</surname><given-names>A</given-names></name><name><surname>Behillil</surname><given-names>S</given-names></name><name><surname>Enouf</surname><given-names>V</given-names></name><name><surname>Caro</surname><given-names>V</given-names></name><name><surname>Mailles</surname><given-names>A</given-names></name><name><surname>Che</surname><given-names>D</given-names></name><name><surname>Manuguerra</surname><given-names>JC</given-names></name><name><surname>Mathieu</surname><given-names>D</given-names></name><name><surname>Fontanet</surname><given-names>A</given-names></name><name><surname>van der Werf</surname><given-names>S</given-names></name><collab>MERS-CoV Study Group</collab></person-group><article-title>Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission</article-title><source>Lancet</source><year>2013</year><volume>381</volume><fpage>2265</fpage><lpage>2272</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(13)60982-4</pub-id><?supplied-pmid 23727167?><pub-id pub-id-type="pmid">23727167</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hijawi</surname><given-names>B</given-names></name><name><surname>Abdallat</surname><given-names>M</given-names></name><name><surname>Sayaydeh</surname><given-names>A</given-names></name><name><surname>Alqasrawi</surname><given-names>S</given-names></name><name><surname>Haddadin</surname><given-names>A</given-names></name><name><surname>Jaarour</surname><given-names>N</given-names></name><name><surname>Alsheikh</surname><given-names>S</given-names></name><name><surname>Alsanouri</surname><given-names>T</given-names></name></person-group><article-title>Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation</article-title><source>East Mediterr Health J</source><year>2013</year><volume>19</volume><issue>Suppl 1</issue><fpage>S12</fpage><lpage>S18</lpage><pub-id pub-id-type="doi">10.26719/2013.19.supp1.S12</pub-id><?supplied-pmid 23888790?><pub-id pub-id-type="pmid">23888790</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Zumla</surname><given-names>AI</given-names></name><name><surname>Al-Hakeem</surname><given-names>RF</given-names></name><name><surname>Al-Rabeeah</surname><given-names>AA</given-names></name><name><surname>Stephens</surname><given-names>GM</given-names></name></person-group><article-title>Family cluster of Middle East respiratory syndrome coronavirus infections</article-title><source>N Engl J Med</source><year>2013</year><volume>368</volume><fpage>2487</fpage><lpage>2494</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1303729</pub-id><?supplied-pmid 23718156?><pub-id pub-id-type="pmid">23718156</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><mixed-citation publication-type="other">Who Mers-Cov Research Group. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr. 2013;5.</mixed-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arabi</surname><given-names>YM</given-names></name><name><surname>Arifi</surname><given-names>AA</given-names></name><name><surname>Balkhy</surname><given-names>HH</given-names></name><name><surname>Najm</surname><given-names>H</given-names></name><name><surname>Aldawood</surname><given-names>AS</given-names></name><name><surname>Ghabashi</surname><given-names>A</given-names></name><name><surname>Hawa</surname><given-names>H</given-names></name><name><surname>Alothman</surname><given-names>A</given-names></name><name><surname>Khaldi</surname><given-names>A</given-names></name><name><surname>Al Raiy</surname><given-names>B</given-names></name></person-group><article-title>Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection</article-title><source>Ann Intern Med</source><year>2014</year><volume>160</volume><fpage>389</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.7326/M13-2486</pub-id><?supplied-pmid 24474051?><pub-id pub-id-type="pmid">24474051</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaki</surname><given-names>AM</given-names></name><name><surname>van Boheemen</surname><given-names>S</given-names></name><name><surname>Bestebroer</surname><given-names>TM</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Fouchier</surname><given-names>RA</given-names></name></person-group><article-title>Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</article-title><source>N Engl J Med</source><year>2012</year><volume>367</volume><fpage>1814</fpage><lpage>1820</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1211721</pub-id><?supplied-pmid 23075143?><pub-id pub-id-type="pmid">23075143</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Tawfiq</surname><given-names>JA</given-names></name><name><surname>Hinedi</surname><given-names>K</given-names></name><name><surname>Ghandour</surname><given-names>J</given-names></name><name><surname>Khairalla</surname><given-names>H</given-names></name><name><surname>Musleh</surname><given-names>S</given-names></name><name><surname>Ujayli</surname><given-names>A</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients</article-title><source>Clin Infect Dis</source><year>2014</year><volume>59</volume><fpage>160</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu226</pub-id><?supplied-pmid 24723278?><pub-id pub-id-type="pmid">24723278</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajlan</surname><given-names>AM</given-names></name><name><surname>Ahyad</surname><given-names>RA</given-names></name><name><surname>Jamjoom</surname><given-names>LG</given-names></name><name><surname>Alharthy</surname><given-names>A</given-names></name><name><surname>Madani</surname><given-names>TA</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings</article-title><source>AJR Am J Roentgenol</source><year>2014</year><volume>203</volume><fpage>782</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.2214/AJR.14.13021</pub-id><?supplied-pmid 24918624?><pub-id pub-id-type="pmid">24918624</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zumla</surname><given-names>A</given-names></name><name><surname>Hui</surname><given-names>DS</given-names></name><name><surname>Perlman</surname><given-names>S</given-names></name></person-group><article-title>Middle East respiratory syndrome</article-title><source>Lancet</source><year>2015</year><volume>386</volume><fpage>995</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(15)60454-8</pub-id><?supplied-pmid 26049252?><pub-id pub-id-type="pmid">26049252</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saad</surname><given-names>M</given-names></name><name><surname>Omrani</surname><given-names>AS</given-names></name><name><surname>Baig</surname><given-names>K</given-names></name><name><surname>Bahloul</surname><given-names>A</given-names></name><name><surname>Elzein</surname><given-names>F</given-names></name><name><surname>Matin</surname><given-names>MA</given-names></name><name><surname>Selim</surname><given-names>MA</given-names></name><name><surname>Al Mutairi</surname><given-names>M</given-names></name><name><surname>Al Nakhli</surname><given-names>D</given-names></name><name><surname>Al Aidaroos</surname><given-names>AY</given-names></name><name><surname>Al Sherbeeni</surname><given-names>N</given-names></name><name><surname>Al-Khashan</surname><given-names>HI</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Albarrak</surname><given-names>AM</given-names></name></person-group><article-title>Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia</article-title><source>Int J Infect Dis</source><year>2014</year><volume>29</volume><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2014.09.003</pub-id><?supplied-pmid 25303830?><pub-id pub-id-type="pmid">25303830</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>AR</given-names></name></person-group><source>Smallpox</source><year>1972</year><publisher-loc>Bombay</publisher-loc><publisher-name>The Kothari Book Depot</publisher-name></element-citation></ref><ref id="CR126"><label>126.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Prevention strategies for seasonal influenza in healthcare settings. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm">https://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm</ext-link>. Accessed 17 Apr 2019.</mixed-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merckx</surname><given-names>J</given-names></name><name><surname>Wali</surname><given-names>R</given-names></name><name><surname>Schiller</surname><given-names>I</given-names></name><name><surname>Caya</surname><given-names>C</given-names></name><name><surname>Gore</surname><given-names>GC</given-names></name><name><surname>Chartrand</surname><given-names>C</given-names></name><name><surname>Dendukuri</surname><given-names>N</given-names></name><name><surname>Papenburg</surname><given-names>J</given-names></name></person-group><article-title>Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis</article-title><source>Ann Intern Med</source><year>2017</year><volume>167</volume><fpage>394</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.7326/M17-0848</pub-id><?supplied-pmid 28869986?><pub-id pub-id-type="pmid">28869986</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Middle East Respiratory Syndrome (MERS). Interim Patient under Investigation (PUI) guidance and case definitions. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/mers/case-def.html">https://www.cdc.gov/coronavirus/mers/case-def.html</ext-link>. Accessed 17 Apr 2019.</mixed-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Al-Tawfiq</surname><given-names>JA</given-names></name><name><surname>Makhdoom</surname><given-names>HQ</given-names></name><name><surname>Assiri</surname><given-names>A</given-names></name><name><surname>Alhakeem</surname><given-names>RF</given-names></name><name><surname>Albarrak</surname><given-names>A</given-names></name><name><surname>Alsubaie</surname><given-names>S</given-names></name><name><surname>Al-Rabeeah</surname><given-names>AA</given-names></name><name><surname>Hajomar</surname><given-names>WH</given-names></name><name><surname>Hussain</surname><given-names>R</given-names></name><name><surname>Kheyami</surname><given-names>AM</given-names></name><name><surname>Almutairi</surname><given-names>A</given-names></name><name><surname>Azhar</surname><given-names>EI</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Watson</surname><given-names>SJ</given-names></name><name><surname>Kellam</surname><given-names>P</given-names></name><name><surname>Cotten</surname><given-names>M</given-names></name><name><surname>Zumla</surname><given-names>A</given-names></name></person-group><article-title>Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome</article-title><source>J Infect Dis</source><year>2014</year><volume>210</volume><fpage>1590</fpage><lpage>1594</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiu292</pub-id><?supplied-pmid 24837403?><pub-id pub-id-type="pmid">24837403</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>PC</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name><name><surname>Lau</surname><given-names>SK</given-names></name></person-group><article-title>Epidemiology of coronavirus-associated respiratory tract infections and the role of rapid diagnostic tests: a prospective study</article-title><source>Hong Kong Med J</source><year>2012</year><volume>18</volume><issue>Suppl 2</issue><fpage>22</fpage><lpage>24</lpage><?supplied-pmid 22311356?><pub-id pub-id-type="pmid">22311356</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Evaluating patients for smallpox: acute, generalized vesicular or pustular rash illness protocol. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/smallpox/clinicians/algorithm-protocol.html">https://www.cdc.gov/smallpox/clinicians/algorithm-protocol.html</ext-link>. Accessed 17 Apr 2019.</mixed-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>TC</given-names></name><name><surname>Fan-Ngai Hung</surname><given-names>I</given-names></name><name><surname>Ka-Hay Luk</surname><given-names>J</given-names></name><name><surname>Chu</surname><given-names>LW</given-names></name><name><surname>Hon-Wai</surname><given-names>CF</given-names></name></person-group><article-title>Effectiveness of influenza vaccination in institutionalized older adults: a systematic review</article-title><source>J Am Med Dir Assoc</source><year>2014</year><volume>15</volume><fpage>226.e1</fpage><lpage>226.e6</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2013.10.008</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>CR</given-names></name><name><surname>McKenzie</surname><given-names>BC</given-names></name><name><surname>Hashim</surname><given-names>AB</given-names></name><name><surname>Harris</surname><given-names>RC</given-names></name><collab>University of Nottingham Influenza and the ImmunoCompromised (UNIIC) Study Group</collab><name><surname>Nguyen-Van-Tam</surname><given-names>JS</given-names></name></person-group><article-title>Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology</article-title><source>J Infect Dis</source><year>2012</year><volume>206</volume><fpage>1250</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis487</pub-id><?supplied-pmid 22904335?><pub-id pub-id-type="pmid">22904335</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grohskopf</surname><given-names>LA</given-names></name><name><surname>Sokolow</surname><given-names>LZ</given-names></name><name><surname>Broder</surname><given-names>KR</given-names></name><name><surname>Walter</surname><given-names>EB</given-names></name><name><surname>Fry</surname><given-names>AM</given-names></name><name><surname>Jernigan</surname><given-names>DB</given-names></name></person-group><article-title>Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 influenza season</article-title><source>MMWR Recomm Rep</source><year>2018</year><volume>67</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.15585/mmwr.rr6703a1</pub-id><?supplied-pmid 30141464?><pub-id pub-id-type="pmid">30141464</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paules</surname><given-names>CI</given-names></name><name><surname>Marston</surname><given-names>HD</given-names></name><name><surname>Eisinger</surname><given-names>RW</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name><name><surname>Fauci</surname><given-names>AS</given-names></name></person-group><article-title>The pathway to a universal influenza vaccine</article-title><source>Immunity</source><year>2017</year><volume>47</volume><fpage>599</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.09.007</pub-id><?supplied-pmid 29045889?><pub-id pub-id-type="pmid">29045889</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm">https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm</ext-link>. Accessed 19 Apr 2019.</mixed-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayden</surname><given-names>FG</given-names></name><name><surname>Sugaya</surname><given-names>N</given-names></name><name><surname>Hirotsu</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>de Jong</surname><given-names>MD</given-names></name><name><surname>Hurt</surname><given-names>AC</given-names></name><name><surname>Ishida</surname><given-names>T</given-names></name><name><surname>Sekino</surname><given-names>H</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Portsmouth</surname><given-names>S</given-names></name><name><surname>Kawaguchi</surname><given-names>K</given-names></name><name><surname>Shishido</surname><given-names>T</given-names></name><name><surname>Arai</surname><given-names>M</given-names></name><name><surname>Tsuchiya</surname><given-names>K</given-names></name><name><surname>Uehara</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>A</given-names></name><name><surname>Baloxavir Marboxil Investigators</surname><given-names>G</given-names></name></person-group><article-title>Baloxavir marboxil for uncomplicated influenza in adults and adolescents</article-title><source>N Engl J Med</source><year>2018</year><volume>379</volume><fpage>913</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1716197</pub-id><?supplied-pmid 30184455?><pub-id pub-id-type="pmid">30184455</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Measles vaccines: WHO position paper, April 2017&#x02013;recommendations</article-title><source>Vaccine</source><year>2019</year><volume>37</volume><fpage>219</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2017.07.066</pub-id><?supplied-pmid 28760612?><pub-id pub-id-type="pmid">28760612</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Measles (Rubeola): for healthcare professionals. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/measles/hcp/index.html">https://www.cdc.gov/measles/hcp/index.html</ext-link>. Accessed 19 Apr 2019.</mixed-citation></ref><ref id="CR140"><label>140.</label><mixed-citation publication-type="other">Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2005:CD001479.</mixed-citation></ref><ref id="CR141"><label>141.</label><mixed-citation publication-type="other">World Health Organization. Measles and vitamin A. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/wer/2009/wer8435.pdf#page=3">https://www.who.int/wer/2009/wer8435.pdf#page=3</ext-link>. Accessed 19 Apr 2019.</mixed-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>JF</given-names></name><name><surname>Lau</surname><given-names>SK</given-names></name><name><surname>To</surname><given-names>KK</given-names></name><name><surname>Cheng</surname><given-names>VC</given-names></name><name><surname>Woo</surname><given-names>PC</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease</article-title><source>Clin Microbiol Rev</source><year>2015</year><volume>28</volume><fpage>465</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1128/CMR.00102-14</pub-id><?supplied-pmid 25810418?><pub-id pub-id-type="pmid">25810418</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albarrak</surname><given-names>AM</given-names></name><name><surname>Stephens</surname><given-names>GM</given-names></name><name><surname>Hewson</surname><given-names>R</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name></person-group><article-title>Recovery from severe novel coronavirus infection</article-title><source>Saudi Med J</source><year>2012</year><volume>33</volume><fpage>1265</fpage><lpage>1269</lpage><?supplied-pmid 23232672?><pub-id pub-id-type="pmid">23232672</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omrani</surname><given-names>AS</given-names></name><name><surname>Saad</surname><given-names>MM</given-names></name><name><surname>Baig</surname><given-names>K</given-names></name><name><surname>Bahloul</surname><given-names>A</given-names></name><name><surname>Abdul-Matin</surname><given-names>M</given-names></name><name><surname>Alaidaroos</surname><given-names>AY</given-names></name><name><surname>Almakhlafi</surname><given-names>GA</given-names></name><name><surname>Albarrak</surname><given-names>MM</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Albarrak</surname><given-names>AM</given-names></name></person-group><article-title>Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study</article-title><source>Lancet Infect Dis</source><year>2014</year><volume>14</volume><fpage>1090</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(14)70920-X</pub-id><?supplied-pmid 25278221?><pub-id pub-id-type="pmid">25278221</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>K</given-names></name><name><surname>Cimon</surname><given-names>K</given-names></name><name><surname>Severn</surname><given-names>M</given-names></name><name><surname>Pessoa-Silva</surname><given-names>CL</given-names></name><name><surname>Conly</surname><given-names>J</given-names></name></person-group><article-title>Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e35797</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0035797</pub-id><?supplied-pmid 22563403?><pub-id pub-id-type="pmid">22563403</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arita</surname><given-names>I</given-names></name></person-group><article-title>Smallpox vaccine and its stockpile in 2005</article-title><source>Lancet Infect Dis</source><year>2005</year><volume>5</volume><fpage>647</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70242-5</pub-id><?supplied-pmid 16183519?><pub-id pub-id-type="pmid">16183519</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>BW</given-names></name><name><surname>Damon</surname><given-names>IK</given-names></name><name><surname>Pertowski</surname><given-names>CA</given-names></name><name><surname>Meaney-Delman</surname><given-names>D</given-names></name><name><surname>Guarnizo</surname><given-names>JT</given-names></name><name><surname>Beigi</surname><given-names>RH</given-names></name><name><surname>Edwards</surname><given-names>KM</given-names></name><name><surname>Fisher</surname><given-names>MC</given-names></name><name><surname>Frey</surname><given-names>SE</given-names></name><name><surname>Lynfield</surname><given-names>R</given-names></name><name><surname>Willoughby</surname><given-names>RE</given-names></name></person-group><article-title>Clinical guidance for smallpox vaccine use in a postevent vaccination program</article-title><source>MMWR Recomm Rep</source><year>2015</year><volume>64</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.15585/mmwr.rr6404a1</pub-id><?supplied-pmid 25695372?><pub-id pub-id-type="pmid">25695372</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feery</surname><given-names>BJ</given-names></name></person-group><article-title>The efficacy of vaccinial immune globulin. A 15-year study</article-title><source>Vox Sang</source><year>1976</year><volume>31</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1159/000467368</pub-id><?supplied-pmid 1007152?><pub-id pub-id-type="pmid">1007152</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharp</surname><given-names>JC</given-names></name><name><surname>Fletcher</surname><given-names>WB</given-names></name></person-group><article-title>Experience of anti-vaccinia immunoglobulin in the United Kingdom</article-title><source>Lancet</source><year>1973</year><volume>1</volume><fpage>656</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(73)92215-0</pub-id><?supplied-pmid 4121857?><pub-id pub-id-type="pmid">4121857</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mucker</surname><given-names>EM</given-names></name><name><surname>Goff</surname><given-names>AJ</given-names></name><name><surname>Shamblin</surname><given-names>JD</given-names></name><name><surname>Grosenbach</surname><given-names>DW</given-names></name><name><surname>Damon</surname><given-names>IK</given-names></name><name><surname>Mehal</surname><given-names>JM</given-names></name><name><surname>Holman</surname><given-names>RC</given-names></name><name><surname>Carroll</surname><given-names>D</given-names></name><name><surname>Gallardo</surname><given-names>N</given-names></name><name><surname>Olson</surname><given-names>VA</given-names></name><name><surname>Clemmons</surname><given-names>CJ</given-names></name><name><surname>Hudson</surname><given-names>P</given-names></name><name><surname>Hruby</surname><given-names>DE</given-names></name></person-group><article-title>Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (smallpox)</article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><fpage>6246</fpage><lpage>6253</lpage><pub-id pub-id-type="doi">10.1128/AAC.00977-13</pub-id><?supplied-pmid 24100494?><pub-id pub-id-type="pmid">24100494</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Pevear</surname><given-names>DC</given-names></name><name><surname>Davies</surname><given-names>MH</given-names></name><name><surname>Collett</surname><given-names>MS</given-names></name><name><surname>Bailey</surname><given-names>T</given-names></name><name><surname>Rippen</surname><given-names>S</given-names></name><name><surname>Barone</surname><given-names>L</given-names></name><name><surname>Burns</surname><given-names>C</given-names></name><name><surname>Rhodes</surname><given-names>G</given-names></name><name><surname>Tohan</surname><given-names>S</given-names></name><name><surname>Huggins</surname><given-names>JW</given-names></name><name><surname>Baker</surname><given-names>RO</given-names></name><name><surname>Buller</surname><given-names>RL</given-names></name><name><surname>Touchette</surname><given-names>E</given-names></name><name><surname>Waller</surname><given-names>K</given-names></name><name><surname>Schriewer</surname><given-names>J</given-names></name><name><surname>Neyts</surname><given-names>J</given-names></name><name><surname>DeClercq</surname><given-names>E</given-names></name><name><surname>Jones</surname><given-names>K</given-names></name><name><surname>Hruby</surname><given-names>D</given-names></name><name><surname>Jordan</surname><given-names>R</given-names></name></person-group><article-title>An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>13139</fpage><lpage>13149</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.20.13139-13149.2005</pub-id><?supplied-pmid 16189015?><pub-id pub-id-type="pmid">16189015</pub-id></element-citation></ref></ref-list></back></article>